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Abstract
Of the eleven species of bacteria that comprise the genus Yersinia of the family
Enterobacteriaceae three speCIes are pathogenic for humans. Yersinia
pseudotuberculosis and Yersinia enterocolitica usually cause a mild, self-limiting
mesenteric lymphadenitis or ileitis. Yersinia pestis causes a highly invasive often fatal
disease known as plague. All three elaborate a type three secretion system that is
essential for virulence and encoded on closely related plasmids. In Y pestis all the
effectors, structural components and chaperones are encoded on the 70kb plasmid, pCD I.
Of these , LcrV from enterocolitica has been implicated in playing an
immunosuppressive role through its interaction with host Toll-like receptor 2 (TLR2) and
induction of IL- IO. Through expression and purification of recombinant LcrV from
Escherichia coli we show that only high molecular weight species of rLcrV are able to
stimulate TLR2. In a highly sensitive subcutaneous mouse infection model we
demonstrate no difference in the time to death between TLR2-sufficient or deficient
mice. Analysis of cytokine levels between these two genotypes also shows no significant
difference between splenic IL- IO and IL-6 or levels of bacteria. We conclusively show
that this interaction, if it does occur, plays no significant role in vivo.
In a separate set of experiments , we also determined that the expression of
, a peptide shown to be responsible for 37 dependent inhibition of invasion by 
pestis in vitro was significantly decreased under high oxygen conditions. This led us to
re-examine the invasion phenotype both in vitro and in vivo. These results give new
insights into virulence gene expression in Y pestis by environmental cues other than
temperature
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Introduction 
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Plague and the biology of Yersinia pestis 
 
Of the eleven species of bacteria that comprise the genus Yersinia of the family 
Enterobacteriaceae, three species are pathogenic for humans. Yersinia 
pseudotuberculosis and Yersinia enterocolitica usually cause a mild, self-limiting 
mesenteric lymphadenitis or ileitis.  In contrast, Yersinia pestis causes a highly invasive 
often fatal disease known as plague.  Plague has been responsible for three major 
pandemics, each involving millions of deaths.  The second of these, often known as the 
“Black Death” (1347-1351), killed close to one third of the European population.  There 
are currently 1,000 to 3,000 cases of plague a year, mostly in Africa, Asia and South 
America, with 10-15 cases occurring in rural areas of the Southwestern United States.  It 
is clear that Y. pestis is derived from a single clone of Y. pseudotuberculosis, and 
estimates based on a “mutational clock” theory indicate that this divergence occurred 
only 1500 to 20,000 years ago [1].  While the enteric yersiniae are transmitted to humans 
via the oral-fecal route, transmission of Y. pestis mainly occurs through the bite of 
infected fleas, an adaptation facilitated by the acquisition of two plasmids pMT1, pPCP1.  
pMT1 encodes genes necessary for colonization of the flea gut, while pPCP1 enhances 
dissemination from flea bite to bloodstream [2, 3].   
 
Yersinia pestis is endemic in rodent populations in the southwestern United 
States, Africa, South America and Asia.  The rat flea, Xenopsylla cheopis, feeds on 
infected rodents and other small mammals, engulfing bacteria-laden blood meals.  Within 
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the flea gut, the bacteria produce two products of particular importance.  A phospholipase 
D (Ymt) that is essential for protection from flea antibacterial defenses, and a surface 
polysaccharide that promotes aggregation of the bacteria and their adherence to structures 
in the flea proventriculus [4, 5].  This adhesion and aggregation occludes the 
proventriculus preventing ingestion of blood, causing the starving fleas to bite repeatedly, 
regurgitating Y. pestis into the bite wounds at each attempt.  Fleas can infect a variety of 
rodent species, including many species of ground squirrels.  These serve as important 
reservoirs in nature, as do rats, prairie dogs, and marmots.  Human infection usually 
results from fleas infected by these natural hosts.  In vivo experiments have demonstrated 
that following the bite of an infected flea, the pPCP1-encoded outer membrane protease, 
Pla, greatly enhances dissemination from the intradermal site [6].  Bacteria that lack this 
protease cause only a mild inflammation at the wound site and are completely unable to 
spread into the neighboring lymphatic system. 
 
Spread into the lymphatics results in massive proliferation of the bacteria within 
draining lymph nodes, resulting in gross swelling and necrosis.  Inguinal, cervical or 
axillary nodes are frequently involved.  These engorged and painful nodes are termed 
“buboes”, and the resulting disease is known as bubonic plague.  In classical bubonic 
plague, bacteria escape the nodes and enter the blood leading to fatal systemic infection.  
However, entry into the blood following fleabite may occur without bubo formation, 
resulting in primary septicemic plague.  Dissemination via blood results in infection of 
many organs, including liver, spleen, lungs, and meninges, accompanied by extremely 
high levels of bacteremia.  When untreated, bubonic and septicemic plague cause about 
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50% mortality. Lung involvement, or secondary pneumonic plague, can result in person-
to-person transmission via contaminated droplets aerosolized through coughing.  
Transmission by aerosol results in primary pneumonic plague, which is universally fatal 
if untreated.  Effective treatment requires institution of appropriate therapy within 20 
hours of the onset of symptoms, a point at which the disease is difficult to recognize 
unless the index of suspicion is very high. The high mortality, ease of dissemination, and 
potential for secondary transmission of pneumonic plague make Y. pestis a significant 
cause for concern with respect to biological terrorism and warfare.   
 
Evasion of Innate Immunity through thermally inducible virulence factors 
 
During the course of infection, bacteria are able to reach extraordinary densities in 
the blood, up to 108 CFU per milliliter.  This high density insures infection of feeding 
fleas.  The ability of Y. pestis to attain this high concentration in the blood poses two 
interesting questions.  How do the bacteria escape the antibacterial defenses that usually 
keep superficial infections localized?  And how do the bacteria prevent induction of fatal 
septic shock before these high densities are achieved?  The answers to both these 
questions lie in the ability of Y. pestis to manipulate the mammalian innate immune 
system. Multiple bacterial systems are involved, and often share a common property: 
activation by temperatures above 34°C.  This allows expression within the mammalian 
host, but not the flea.  
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LPS 
 Toll-like receptors are central components of the mammalian innate immune 
system.  So far, ten distinct human receptors have been identified, each able to recognize 
general motifs from bacterial, viral or fungal pathogens.  Stimulation of these receptors 
frequently induces the expression of pro-inflammatory cytokines like TNF and IFN-γ.  
For example, lipopolysaccharide (LPS) is an immunodominant molecule expressed on 
the surface of Gram-negative bacteria that is specifically recognized by host Toll-like 
receptor 4 (TLR4) in complex with MD-2 [7].  LPS is typically composed of a lipid A 
portion anchored in the outer membrane, a polysaccharide core structure and an O-
antigen, composed of repeating oligosaccharides.  Y. pestis completely lacks the O-
antigen structure and modifies the lipid A portion as to evade immune surveillance [8-
10]. 
 
 Rebeil et al. and Knirel et al. demonstrated that the lipid A portion of the Yersinia 
pestis LPS structure is thermally-regulated [11, 12].  At 26ºC, the lipid A portion of the 
LPS molecule is hexa-acylated, similarly to the LPS of E. coli [13].   A “missing” late 
acetyltransferase (lpxL) within the Y. pestis genome renders the lipid A portion 
predominantly tetra-acylated at 37ºC [14].  In vitro experiments demonstrate the 
importance of a modified LPS structure in virulence: the hexa-acylated form is able to 
stimulate TLR4, whereas the tetra-acylated form cannot [14].  These experiments also 
show that expression of the late acetyltransferase, lpxl, in wildtype Y. pestis leads to the 
addition of two additional acyl chains, resulting in a hexa-acylated lipid A at 37ºC.  
Infection experiments in wildtype mice demonstrate that the expression of a hexa-
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acylated lipid A at 37ºC renders Y. pestis avirulent.  However, in TLR4-/- mice, 
expression of hexa-acylated lipid A has no effect on virulence [14].  The contribution of a 
non-stimulatory LPS is an adaptation of Y. pestis to survive in the host by evading innate 
immunity, and may also prevent early onset of septic shock. 
 
Type Three Secretion System  
Many Gram-negative bacterial pathogens utilize a contact-dependent type three 
secretion system (TTSS) to inject their bacterial products directly into host cell cytosol. 
Upon host cell contact, proteins are translocated from the bacterial cytoplasm through a 
needle-like structure, or injectisome, that spans the inner and outer membrane.  The tip of 
the needle connects to the host cell membrane and allows the bacterial proteins, or 
effectors, to enter the cell cytoplasm and interact with their intracellular targets.  
Typically, the function of these effectors is to modulate signaling pathways and functions 
based on cytoskeletal activity such as phagocytosis. 
 
All three pathogenic Yersinia species elaborate a TTSS that is essential for 
virulence and encoded on closely related plasmids. In Y. pestis, all the effectors, 
structural components and chaperones are encoded on the 70kb plasmid, pCD1. Strains 
deficient in pCD1 are highly attenuated in vivo [15-17].  The assembly of the 
injectisomes and synthesis of effectors occurs only at 37°C. Upon host-cell contact, the 
injectisome is activated and the effectors are delivered directly into host cell cytosol.  The 
collection of intracellular effectors, termed Yops (Yersinia outer proteins), inhibit 
signaling cascades controlling phagocytosis (YopH, YopE, YopM), induce apoptosis and 
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inhibit cytokine production (YopJ) [18]. Three translocator proteins, YopB, YopD and 
LcrV (or V antigen) are required for efficient delivery of the Yops.  Many studies suggest 
that YopB/D insert directly into the host cell membrane [19-21].  LcrV is necessary for 
both high-level expression of the Yops and as a structural component of the needle, and 
recently it has been suggested that it may also have an immunomodulatory role [22-24].  
Studies using recombinant Y. enterocolitica LcrV expressed and purified from E. coli 
have shown an ability to induce the anti-inflammatory cytokine, IL-10, in a TLR2-
dependent manner [25].  This ability, though not exhaustively tested for Y. pestis LcrV, 
has also been suggested for Y. pestis LcrV. 
 
Pla 
The only recognized virulence factor encoded on the 9.5 kb plasmid, pPCP1, is 
the integral, outer membrane protein, Pla, a multifunctional, 34.6 kD protein with 
plasminogen activator activity [2]. Unlike many of the virulence factors discussed here, 
Pla is constitutively expressed and active at both 30°C and 37°C.  Sequencing of the pla 
gene reveals homology to ompT of Escherichia coli and PgtE of Salmonella 
typhimurium, proteases with weak plasminogen activator activity in comparison to Pla 
[26].  Though it possesses no significant homology to any known eukaryotic plasminogen 
activators, the activity of Pla is similar to that of human tissue or urokinase plasminogen 
activator, cleaving plasminogen at the same R560-V561 site, releasing the active plasmin 
portion of the molecule [6].  The protease activity of Pla also degrades the C3b 
component of complement [6] and α2-antiplasmin, an inhibitor of soluble plasmin.  
Collectively, these activities promote the degradation of fibrin.  However, the most 
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prominent effect of Pla at the level of individual lesions is the suppression of neutrophil 
accumulation.  In the liver, Pla- Y. pestis are rapidly surrounded by neutrophils to form a 
microabcess.  In contrast, Pla+ bacteria grow freely packed within liver sinusoids with no 
sign of local inflammation [6].  The mechanism underlying this effect is not understood. 
 
Several groups speculate that the central role of Pla during a subcutaneous 
infection is degradation of the fibrin matrices, via its plasminogen activator activity, that 
might otherwise encapsulate the bacteria at intradermal wound sites.  It has been shown 
by several groups that in vivo, Pla enhances the progression to systemic disease after 
intradermal inoculation, but not for intravenous inoculation.  Pla mutants are fully 
virulent after intravenous challenge compared to wildtype, but the LD50 increases a 
million-fold after subcutaneous infection of Pla-deficient strains compared to wildtype.  
Experiments conducted with plasminogen-deficient mice reveal that they are less 
susceptible to infection after subcutaneous challenge with Y. pestis [27]. 
 
In addition to its protease activity, Pla has been shown to have both adhesive and 
invasive properties in vitro.  Lähteenmäki et al. observed E. coli–expressing Pla, but not 
E. coli alone, was able to bind to the extracellular matrix components, vitronectin and 
laminin [28].  In addition they observed that laminin, but not vitronectin, was degraded 
by Pla in the presence of exogenous plasminogen. In a subsequent study, they observed 
that E. coli-expressing Pla, but not E. coli alone, was able to invade endothelial cells in 
vitro [29].  A role for Pla-mediated adhesive and/or invasive functions has not been 
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demonstrated in vivo, nor has it been demonstrated that protease activity is absolutely 
required for adhesion and/or invasion. 
 
The activities of Pla required for the progression of primary pneumonic plague are 
largely not known.  Lathem et al. demonstrated that Pla is required for Y. pestis to cause 
fulminant pneumonia in intranasally infected mice; only 50% of mice infected with 1 x 
104 CFU Pla-deficient Y. pestis succumbed to plague after 7 days, compared to 100% of 
mice infected with the wildtype strain, CO92 [30].  Infection of mice with Pla-deficient 
strains resulted in a significant reduction in bacterial load in the spleens and lungs after 
48 hours compared to wildtype strain, CO92 (105 higher CFU/gram of lung in wildtype 
infected mice).  However, they find that Pla is not essential for dissemination from the 
lung, unlike results from experiments where mice were infected subcutaneously.  In 
contrast, studies by Welkos et al. demonstrate that the requirement for Pla is not 
substantial.  They report only a 4-fold increase in the LD50 when mice are infected by 
aerosol with a pPCP1- strain compared to wildtype CO92 [31].   These differences could 
be due to growth conditions of the bacteria.  For aerosol infection, Welkos et al. 
consistently grow the bacteria in liquid culture at 30°C, whereas Lathem et al. grew their 
bacteria in flasks at 37°C, conditions which the bacteria will be primed with many 
virulence determinants such as TTSS, F1 and non-stimulatory LPS [15, 30, 32 {Welkos, 
2002 #52]}. 
Interestingly, the plasminogen activator activity of Pla is largely dependent upon 
the structure of the bacterial lipopolysaccharide [33].   As previously mentioned, Y. pestis 
is unique in that its LPS structure contains only the outer membrane-bound lipid A 
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portion and a polysaccharide core; it completely lacks an O-antigen.  “Smooth-type” LPS 
has O-antigen, composed of repeating oligosaccharides, whereas rough-type LPS lacks a 
long chain O-antigen. Studies by Kukkonen et al. observed that purified His6-Pla 
reconstituted with rough (Re) type, but not smooth, lipopolysaccharide (LPS) from 
Salmonella enterica was able to effectively activate plasminogen [33].  It is likely that 
this effect is merely the result of steric hindrance, smooth LPS preventing access of the 
94 kD plasminogen molecule to the active site of the protease located at the outer 
membrane surface.  The structure of the fatty acid component of LPS does not appear 
crucial to Pla activity.  A strain modified to express hexa-acylated LPS has similar Pla 
activity as to wild type, tetra-acyl LPS expressing strain [34].  Moreover, Pla activity 
does not change with temperature, although LPS structure is modified. 
 
F1 
Inhibition of phagocytosis is also accomplished, but to a lesser extent, by the 
production of a peptide “capsule” at 37°C [35].  The existence of this structure has been 
known for many years, and has been historically referred to as the Fraction 1 or F1 
antigen. It is in fact not a true capsule, but comprises a highly expressed chaperone/usher 
type pilus that is readily shed by the bacteria.  Encoded on the largest plasmid, pMT1, 
caf1 is located within an operon that also encodes the regulator (caf1R), the chaperone 
(caf1M) and usher protein (caf1A) required for pilus biogenesis [36-38].   The 28.7 kD 
Caf1M protein shares homology with PapD, a chaperone protein of P pili in 
uropathogenic Escherichia coli [36] and Caf1A shares homology with PapC, the usher 
protein for P pili assembly [38].  Sequence analysis reveals homology between caf1R and 
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proteins of the AraC family, known to be DNA-binding transcription regulators. Though 
the mechanism whereby caf1R regulates caf1 is not well understood, Karlyshev et al. 
speculate that caf1R is a positive regulator, as a C-terminal deletion mutant of caf1R 
within the caf1 operon expressed on a plasmid in E. coli retains the ability to generate F1 
monomers [39].  
 
F1 subunits of 15.5 kDa spontaneously self-assemble into pili that are readily 
shed from the bacteria during in vitro growth.  Early work by Cavanaugh and Randall 
demonstrated that bacteria expressing F1 are resistant to phagocytosis by monocytes, but 
that phagocytosed F1-negative bacteria can replicate within the phagocyte and upon 
release from the cell were subsequently resistant to phagocytosis [40].  More recently, it 
was shown that production of F1 inhibits phagocytosis by the macrophage-like cell line, 
J774.1, as well as epithelial cell uptake by A549 cells [35, 41]. However, the role of F1 in 
vivo seems minor in comparison to TTSS, as studies have shown that F1 deletion mutants 
or strains lacking the entire pMT1 plasmid are fully virulent in non-human primates 
challenged by aerosol [42].   
 
In addition, F1-deficient strains have been isolated from plague-infected 
individuals and from mice initially infected with a F1-sufficient strain of Y. pestis 
[43{{Burrows, 1958 #231] Friedlander, 1995 #230} [44].  However, the role of F1 in 
pathogenesis may be organism-specific, as a moderate loss of virulence is observed in 
rats and guinea pigs infected with F1-deficient strains [45].  Thus, the true function of F1 
during human infection is unclear.  To date, the capsule peptide, F1, and the 
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multifunctional TTSS protein, LcrV, are the only recognized vaccine antigens providing 
strong protection against Y. pestis infection [46-50]. 
 
 Collectively, the expression of the type three secretion system (TTSS), F1 capsule 
peptide, the Pla protease and a non-stimulatory LPS allow Yersinia pestis to disseminate 
and replicate virtually unnoticed by the mammalian innate immune system, allowing 
bacteria to reach extraordinarily high densities in the blood.  The thermal regulation on 
TTSS, F1 and LPS demonstrate the importance of bacterial growth temperature during 
infection studies; the state of the bacteria with respect to these structures at the time of 
infection may influence colonization and the subsequent course of disease. 
 
Other Recognized Virulence Factors of Yersinia pestis 
 
The acquisition of iron and the pgm locus 
For bacterial pathogens, the ability to acquire iron in vivo is crucial for full 
virulence.  Iron is tightly sequestered by the mammalian proteins, transferrin and 
lactoferrin.  Encoded on the chromosome of Y. pestis is a 102 kb segment of DNA called 
the pgm locus, initially identified for ability of bacteria to bind large amounts of hemin or 
Congo Red (pigmentation) from solid media at 26ºC, but not 37ºC [51, 52].  Within this 
locus is the hmsHFRS operon, encoding genes that produce enzymes required for the 
synthesis of the surface polysaccharide responsible for hemin and Congo red binding, and 
the yersiniabactin genes (ybt genes and psn) that synthesize Y. pestis siderophore [5, 53].  
Due to recombination between flanking insertion sequences (IS100) with the same 
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orientation, the 102 kb pgm locus is spontaneously lost at a rate of 10-5 [54-56].  Loss of 
the entire locus results in a significant decrease in virulence; the LD50 for s.c.-infected 
mice increases from 2 to 107  CFU and LD50 for aerosol-infected mice increases from 2.3 
x 104  to 106 CFU [31].  Loss of the hms operon has little effect on virulence when mice 
are infected subcutaneously [5].  Genes involved in the acquisition of iron are generally 
considered the most important virulence determinants for mammalian infection encoded 
within the pgm locus, although other genes may have important as yet unidentified 
effects.  The polysaccharide produced by the hms system appears to play an important 
role in adherence of the bacteria to each other and to structures in the flea proventriculus, 
allowing the bacteria to prevent intake of blood to the gut, and as a result enhance 
transmission by causing increased biting and regurgitation by the infected flea. 
 
 pH 6 Antigen 
pH6 antigen, or PsaA, is a chromosomally-encoded, thermally-regulated protein 
that is expressed only at temperatures between 35ºC and 41ºC and between pH 5 and pH 
6.7.  pH 6 antigen forms fimbriae on the surface of the bacteria and, similarly to F1, is 
exported by an usher-chaperone system.  pH 6 antigen has been shown to interact with 
phosphatidycholine on the surface of alveolar epithelial cells and within pulmonary 
surfactant [57].  One study indicates that a pH 6 antigen mutant may be slightly 
attenuated after retro-orbital infection [58].  In a pgm-deficient background, they 
observed a 200-fold increase in the LD50.  The function of pH 6 antigen during infection 
is not known, though its regulation suggests it may be expressed within a bubo or within 
a vacuole.   
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In summary, the coordinate function and regulation, either by temperature or pH, 
of surface-associated virulence factors of Yersinia pestis is important for the 
establishment of disease (Table 1).  Regulation of gene expression through environmental 
cues is crucial for the pathogenesis of plague.  The interaction of these surface-associated 
factors with host cells in vitro may give insight into their putative function in vivo.   
 
The central theme of this thesis is the analysis of interactions between surface-
expressed molecules of Y. pestis and host cells.  Despite the volume of work in this area, 
the functions of many of the key molecules described above remain uncertain, and we 
find some of the functions claimed to be unconvincing and worth revisiting.  
 
In vivo studies in both rodents and non-human primates indicate the ability of Y. 
pestis to rapidly traverse epithelial barriers and into the bloodstream following aerosol or 
oral challenge [42, 59].  Several groups have shown that Y. pestis can mediate its 
internalization into cultured epithelial cells in vitro [41, 60].  We first attempted to 
identify Y. pestis factors involved in bacterial-mediated invasion of epithelial cells in 
vitro as a potential mechanism to cross these host barriers.   However, others and we 
demonstrated that the expression of F1 at 37°C significantly inhibited the invasion 
phenotype [41].  This 37°C-dependent inhibition hindered further examination of this 
phenomenon, as it seemed an unlikely mechanism within a mammalian host.  However, 
during the course of these experiments we found novel and biologically interesting cues 
for expression of F1 that led us to re-examine the invasion phenotype.  These results give 
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new insights into virulence gene expression in Y. pestis by environmental cues other than 
temperature. 
  
In addition to studying the interaction of Y. pestis with epithelial cells in vitro, we 
were also interested in testing the LcrV/TLR2 hypothesis in the context of Y. pestis.  
Multiple groups have demonstrated that recombinant LcrV from Yersinia enterocolitica 
has immunosuppressive effects through in induction of IL-10 and suppression of TNF 
through a TLR2/CD-14 dependent mechanism.  As mentioned previously, LcrV is only 
one of two antigens shown to be immuno-protective against plague.  The claim of its 
immunosuppressive effects has implications for the development of LcrV-based plague 
vaccines.  One study attempted to design a modified Yersinia pestis LcrV molecule that 
lacked TLR2 stimulating ability [61].  After thorough examination, we show that 
stimulation of TLR2 by Y. pestis rLcrV, though it occurs in vitro, has no significant effect 
on the outcome of disease after subcutaneous or intravenous challenge with fully virulent 
Y. pestis. 
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Virulence 
Factor 
Gene Location Main Function in 
Mammals 
Regulated by Effect of Loss 
on LD50* 
pgm locus 
 
Chromosome Iron acquisition constitutive >107(s.c.) 
LPS 
 
Chromosome Innate Immune Evasion temperature, 37°C >106 **(s.c.) 
pH 6 antigen Chromosome Formation of pili temperature, 37°C 
and 
pH ∼ 6.2-6.4 
200-fold (r.o.) 
F1 pMT1 Formation of pili  temperature, 37°C 
 
None*** 
(aerosol) 
Type three 
secretion 
pCD1 Delivery of Yop effectors, 
inhibition of phagocytosis 
 
temperature, 37°C >107 (s.c., i.v.) 
Pla protease pPCP1 Plasminogen activation 
Inhibition of neutrophil 
accumulation 
constitutive 108 (s.c.) 
 
 
 
Table 1.  Summary of Yersinia pestis Surface-Expressed Virulence Factors.  
*Compiled from sources referred to in the text. **Infection of mice with stimulatory 
hexa-acylated lipid A form with bacteria grown at 37°C.  ***As discussed in the text, the 
role of F1 in vivo is not well understood.  Aerosol infection of non-human primates with 
F1+ and F1- bacteria suggest difference in virulence, however this group almost 
exclusively uses 30°C-liquid grown strains for aerosol infection. 
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Chapter Two. 
 
Evaluation of the role of LcrV/TLR2-mediated 
 
immunomodulation in the virulence of Yersinia pestis 
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Introduction 
 
         The three Yersinia species elaborate a type III contact-dependent secretion system 
(T3SS) that is essential for virulence, and encoded on closely related plasmids.  This 
apparatus allows delivery of effector molecules directly into host cell cytosol.   These 
intracellular effectors, termed Yops, inhibit phagocytosis, induce apoptosis, and inhibit 
cytokine induction [18, 62]. Three translocator proteins, YopB, YopD and LcrV are 
required for efficient intracellular delivery of the Yops [62].  LcrV (V-antigen) is a multi-
function protein essential for virulence.   It comprises the tip of the injection needle of the 
T3SS [19, 63, 64], and along with LcrG has a regulatory role in Yop secretion [22].  In 
addition, LcrV has been shown to be one of only two proteins to serve as highly effective 
vaccine antigens against Yersinia pestis [46, 65, 66]. 
 
An immunomodulatory role for LcrV has also been proposed [67].  In vivo studies 
have shown that a recombinant Y. pseudotuberculosis LcrV/Protein A fusion, produced in 
E. coli, suppressed induction of TNF and IFNγ induced by injection of 
lipopolysaccharide (LPS) into Swiss Webster mice, and also enhanced the severity of 
disease and the bacterial burden following infection of treated mice with attenuated Y. 
pestis, Salmonella typhimurium, and Listeria monocytogenes [68]. Further studies 
utilizing recombinant Y. enterocolitica LcrV (rLcrV), also produced in E. coli, 
suppressed zymosan-induced TNF production in C57BL/6 macrophages [69].   It has 
been proposed that rLcrV interacts with both Toll-like receptor 2 (TLR2) and CD14 to 
induce interleukin-10 (IL-10) in transfected HEK293 cells [70]. Candidate residues 
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responsible for this interaction with TLR2 were identified in the N-terminal region of Y. 
enterocolitica LcrV based on the activity of cognate synthetic peptides [70, 71]. Lower 
activity was detected in similar peptides based on Y. pestis and Y. pseudotuberculosis 
LcrV sequence [71].  More recently, Overheim et al.. [72] showed that recombinant His-
tagged LcrV derived from Y. pestis and purified from E. coli, induced IL-10 from murine 
macrophages and human monocytes.  It also suppressed induction of TNF from murine 
macrophages.  This group also showed that deletion of either of two domains within 
LcrV eliminated stimulation of IL-10 secretion, but that deletion of only one of these, 
near the C terminus of the protein, eliminated both induction of IL-10 secretion and 
suppression of TNF.  Neither of these domains corresponds with--or overlaps the 
sequence of--the active peptide identified by Sing et al. in the LcrV of Y. enterocolitica.  
Overheim et al.. also presented evidence that a fragment of LcrV lacking the C terminus--
which includes the domain responsible for suppression of TNF--was an effective vaccine 
against Y. pestis at lower doses than unmodified recombinant LcrV.  
 
Toll-like receptors participate in many aspects of host defense against infections 
[73].  Stimulation of TLR2 results in the induction of pro-inflammatory cyokines such as 
TNF and IL-6.  Like TLR4, the receptor for lipopolysaccharide (LPS), TLR2 is also 
responsible for the release of anti-inflammatory cytokines such as IL-10 and IL-4, 
although these are usually detected at a later time than pro-inflammatory mediators 
induced simultaneously via the same pathway [74, 75].  Curiously, TLR2 has been 
associated with immunosuppression in microorganisms in addition to Y. enterocolitica 
[76, 77], suggesting that exploitation of this pathway as a means to evade innate 
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immunity may be a common strategy among pathogens.  However, no clear mechanistic 
basis for a predominantly immunosuppressive effect of TLR2 stimulation has been 
established. 
 
In this study, we report that Yersinia pestis-derived rLcrV, purified from E. coli 
through Ni-NTA chromatography activates TLR2, as has been reported for Yersinia 
enterocolitica LcrV.  However, further purification through gel filtration indicates that 
only a very high molecular weight multimer or aggregate, which comprises a small 
proportion of total rLcrV, has stimulatory activity.  Stimulation with Yersinia pestis 
LcrV-derived peptides corresponding to stimulatory peptides derived from Yersinia 
enterocolitica LcrV failed to activate TLR2.  In infection experiments, TLR2-deficiency 
in mice had no significant influence on the course of disease, levels of IL-10, or degree of 
inflammation in infected tissue.  Taken together, these results strongly suggest that 
TLR2-mediated induction of IL-10 does not contribute significantly to the virulence of 
Yersinia pestis.  
 
Materials and Methods 
 
Bacterial Strains, Plasmids, Cell Lines, and Reagents.  Virulent Y. pestis strain 
KIM1001[6], biotype mediavalis, was grown and quantified on solid medium (TB) 
containing 10 g Bacto-tryptose, 5 g NaCl, 3 g Beef Extract (paste form, Difco Cat # 
212610) and 15 g agar per liter supplemented with 2.5 mM CaCl2. Although this 
composition is identical to that given for pre-compounded Tryptose Blood Agar Base, we 
 21
have on occasion encountered significant problems with plating efficiency on the latter 
preparation, and therefore chose to work from the individual components. Unless 
otherwise indicated, plates were incubated at 25°C for 48 hours.  prLcrV is described in 
Overheim at. al., and was the kind gift of Olaf Schneewind.  Construction of pLcrVYp is 
described below.  HEK293 cells stably expressing human TLR2-YFP, or empty vector 
pcDNA3 were as described [78].  HEK293-TLR2-YFP/human CD14 cells were 
generated by stably expressing human CD14 in the vector pCEP4, selection in 
hygromycin, followed by FACSorting.  293 cells were maintained in DMEM 
supplemented with 10% FCS and 10μg/ml Ciprofloxacin (Biowhittaker), with addition of 
G418 (0.5 mg/ml, 293-pCDNA3 and 293-TLR2-YFP) or G418 plus hygromycin (400 
U/ml, 293-TLR2-YFP/CD14). Cells were seeded at 3 x 104 per well in 96-well tissue 
culture plates (Costar) and stimulated for 16-18 hours before harvesting supernatant for 
cytokine analysis. LPS, from the E. coli strain 0111:B4, was purchased from Sigma and 
was subjected to two rounds of phenol re-extraction to remove contaminating TLR2 
stimulating lipoproteins [79].  A synthetic triacylated lipohexapeptide Pam 3-CysSerLys4 
(P3C) was purchased from EMC Microcollections (Tuebingen, Germany). Synthetic 
LcrV peptides (HPLC purified to > 98%) were purchased from Genemed Synthesis, Inc. 
 
Recombinant plasmids expressing LcrV from Yersinia pestis.  lcrV from Yersinia 
pestis strain KIM [3] amplified by PCR was cloned into vector pBAD/gIIIB (Invitrogen) 
at NcoI and SalI sites resulting in pLcrVYp. This vector incorporates a signal sequence to 
promote export of the cloned protein to the periplasm.  The signal sequence was included 
both to allow extraction by osmotic shock, and to reduce inclusion body formation.  
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Because osmotic shock proved to have little advantage, more convenient methods of 
extraction were used during preparation of recombinant protein (see below).  The coding 
sequence of the rLcrV in this construct is as follows (cleaved domain of signal sequence 
italicized, non-native residues of mature protein lower case, native residues uppercase): 
mkkllfaiplvvpfyshs tmvMIRAYEQNP...DTSGKvdhhhhhh 
Note the added C-terminal hexahistidyl domain used in purification.   
 
A second recombinant LcrV-producing plasmid, prLcrV, was the kind gift of Olaf 
Schneewind, and is described by Overheim et. al. [72].  This plasmid produces full-length 
rLcrV with the addition an amino-terminal decahistidyl domain. 
 
Expression and Purification of rLcrV.  From plasmid pLcrVYp: Escherichia coli 
LMG194 (Invitrogen) carrying pLcrVYp was grown overnight at 37°C in 2xYT broth 
supplemented with 100 μg/ml ampicillin.   Bacteria were then diluted into 4 L of fresh 
medium to an optical density at 600nm (OD600) of 0.1 and grown at 37°C in a New 
Brunswick Bio Flo 2000 fermenter (5 l/min aeration, 300 rpm agitation, antifoam as 
needed) to an OD600 of 0.5.  Arabinose (0.002%) was then added to induce production 
of LcrV, and incubation continued for an additional 3 h. Cells were harvested by 
centrifugation at 12,000 x g for 10 min, resuspended in 50 ml of 50mM sodium 
phosphate buffer pH 8.0 containing 300 mM NaCl, and sonicated on ice (Branson 
Sonifier 450 with 0.75” solid stepped horn, output power setting 6, run for 4 minutes at 
50% duty cycle).   Alternatively, cells were disrupted via rapid decompression with a pre-
chilled French pressure cell operated at 20,000 psi.  The extract was centrifuged at 10,000 
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x g for 15 min, and the soluble fraction applied to nickel nitrilo-triacetic acid (Ni-NTA) 
column (1 ml bed volume) pre-equilibrated with 30 ml column buffer containing 50mM 
NaH2PO4, 300mM NaCl and 10mM imidazole, pH 8 (Qiagen).  The column was washed 
with 15ml wash buffer containing 50mM NaH2PO4, 300mM NaCl, and 20 mM 
imidazole, pH 8.  Bound protein was eluted in buffer containing 50mM NaH2PO4, 
300mM NaCl, and 250mM imidazole pH 8.  Proteins were subjected to extensive dialysis 
against endotoxin-free PBS (Cambrex), and immediately frozen at -80°C. Protein 
concentrations were determined by absorbance at 280 nm using an extinction coefficient 
of 0.515 calculated from the rLcrV sequence by the method of Gill and von Hippel [80] 
and confirmed by SDS-PAGE. All buffers were prepared using endotoxin-free reagents. 
 
Analysis of purified rLcrV treated with 5 mM dithiothreitol (DTT) by mass spectroscopy 
(LC-MS) yielded a mass consistent with removal of the signal sequence: no material 
corresponding to the full-length precursor form was detected.  
 
ii. Expression and purification from plasmid prLcrV: This plasmid was transformed into 
BL21DE3 and protein production induced and the rLcrV extracted and purified as 
described by Overheim et al. with the following modifications: (1) A French pressure cell 
was used to disrupt the bacteria as described above rather than sonication, (2) Triton X-
114 phase separation and the following size-exclusion chromatography on G25 sephadex 
to remove Triton was omitted.  This material was analyzed identically to rLcrV from 
pLcrVyp via size exclusion chromatography on Superose 12 resin as described below. 
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Size Exclusion Chromotography.  One milligram samples of rLcrV in a 0.3 ml volume 
of PBS were loaded on a PBS-equilibrated Superose 12 column (Amersham Biosciences 
cat # 17-5173-01) and eluted with PBS at a flow rate of 0.54 ml/min.  Endotoxin-free 
PBS (Cambrex) was used for column equilibration and elution.  Absorbance of the eluate 
at 280 nm was monitored.  Fractions of 330 ml were collected in the wells of microtiter 
plates and each tested for ability to stimulate TLR2 via induction of IL-8 as described 
above.   Following each use, the column was washed with 1 M NaOH, followed by 
endotoxin-free water, 0.1 M HCl, and stored in 20% ethanol. 
 
 Mice.  Female C57BL/6 (6-8 weeks of age) were purchased from Jackson Laboratory 
(Bar Harbor, Maine).  TLR2-/- mice were originally a generous gift of S. Akira [81], and 
have now been back-bred to C57BL/6 for 11 generations.   All mice were bred under 
specific-pathogen-free conditions. All animal studies were approved by the Univ. of 
Massachusetts Medical School Institutional Animal Care and Use Committee and all 
relevant policies regarding animal care, biosafety, and security were followed.  
 
Experimental Infection of Mice. To prepare inocula for experimental infection, Y. pestis 
KIM1001 was inoculated heavily onto TB plates from suspensions stored at –70°C in TB 
(no agar) plus 5% glycerol, and incubated at 37°C for 24 hours.  Bacteria were harvested 
from the plate with a loop and resuspended in sterile distilled water with a vortex mixer 
to match a turbidity standard of OD600 0.3.  It was important to use a low ionic strength 
medium for this initial suspension step to achieve good dispersion of the cells.  This 
initial high density suspension was subsequently diluted as required using endotoxin free 
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injection grade PBS.  For survival experiments, 10 age and sex-matched mice per 
treatment group were infected with Yersinia pestis KIM1001 by s.c. injection of 50 μl on 
the nape of the neck.  For i.v. infection experiments, five mice per group  were injected 
with 500 μl of  inoculum containing the indicated doses in the tail vein. Survival was 
monitored every 12 hours for up to 21 days.  All TLR2-/- were individually genotyped 
and bore uniquely numbered ear tags.  For collection of organs, mice were sacrificed 48 
hrs following i.v. infection by pentobarbital overdose followed by cervical dislocation.  
To determine bacterial load, spleens were homogenized in 1 ml of PBS and bacteria in 
the resulting suspension titered by serial dilution and plating. Differences in survival 
were analyzed by Kaplan-Meyer survival analysis and the log rank test. 
 
Histopathology.  Livers were fixed for in neutral buffered 4% formalin, and sections 
stained with hematoxylin/eosin.  
 
Cytokine Determination.  From spleens:  Spleens were homogenized in 1 ml of PBS.  
Following removal of a sample for determination of bacterial titer, Ciprofloxacin 
(100μg/ml final concentration) and protease inhibitor cocktail (Roche catalog # 11-873-
580, 1 x final concentration) were added.  The suspension was centrifuged at 10,000 x g 
for 1 min. The resulting supernatant was filtered to remove bacteria (0.2 μm pore, 
polyvinylidene difluoride, Pall Acrodisc).  Cytokines in the resulting supernatant were 
measured using ELISA kits from BD Pharmingen (moIL-10) or R&D systems (moTNFa, 
moIL-6) according to the manufacturer’s directions.  IL-10 levels were determined twice, 
each time in triplicate from the same set of tissue samples.   
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ii. Cytokine determination from tissue culture:  Culture medium was removed from the 
wells and diluted as required with fresh medium for use in the assays.  IL-8 was 
determined with a kit from R&D Systems (huIL-8).  All cytokine assays were performed 
in triplicate. Significance of observed differences in median cytokine concentrations were 
analyzed by the non-parametric Pittman exact test. 
 
NF-κB luciferase reporter assays.  Cells were transfected with the NF-κB luciferase 
reporter plasmid (a gift of Katherine Fitzgerald, University of Massachusetts Medical 
School) using Genejuice (Promega) as described by the manufacturer.  Following 
stimulation and incubation as indicated, cells were lysed with passive lysis buffer 
(Promega), and luciferase activity was measured by luminometry following addition of 
luciferase substrate. 
 
Results 
 
Preparation of recombinant Y. pestis LcrV.  The lcrV gene from Yersinia pestis strain 
KIM1001 was cloned into the expression vector pBADgIIIB (Invitrogen) resulting in 
pLcrVYp.   (See Materials and Methods for a detailed description of the protein produced 
by this construct.)  rLcrV was expressed and purified by nickel chelation chromatography 
as described in Material and Methods.  This method of purification yields primarily 
dimeric and tetrameric rLcrV as shown by native PAGE, SDS-PAGE, Western blot, and 
gel filtration chromatography (see below.) 
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Yersinia pestis rLcrV and stimulation of TLR2.   Recombinant his-tagged LcrV 
derived from Y. enterocolitica (rLcrVYe) has been reported to activate TLR2 in a CD14-
dependent manner [70].  In these reports, LcrV from Y. enterocolitica was cloned and 
expressed in E. coli with N-terminal 6x His tag in the vector pQE30 (Qiagen), and 
purified by Ni++-chelation chromatography.   To determine if similar rLcrV preparations 
derived the Yersinia pestis lcrV gene are also able to stimulate TLR2, we transfected 
HEK293 cells with TLR2 either in the presence or absence of co-transfected CD14 and 
stimulated them for 18 hours with rLcrV purified as described above. As a measure of 
TLR2-stimulating activity, cell supernatants were assayed for interleukin-8 (IL-8) by 
capture ELISA.   As shown in Figure 1A, TLR2 is required for induction of IL-8 by 
rLcrV, and this induction is enhanced by, but not dependent upon, the co-expression of 
CD14. These observations are similar to the results reported by Sing et al. for rLcrVYe, 
except that we find enhancement, rather than a strict requirement, for CD14. 
Because Sing et al. relied primarily on an NF-kB reporter construct to indicate TLR2 
activation in the HEK293/TLR2/CD14 system, we also examined activation with a 
similar reporter construct.  The results (Fig. 1C) were consistent with the observations 
made using IL-8 release. 
 
Yersinia pestis LcrV synthetic peptides fail to stimulate TLR2.  Peptides identical to 
specific domains of Y. enterocolitica LcrV and capable of stimulating TLR2 have been 
previously described [70, 71]. These are derived from the N-terminal globular portion 
preceding alpha helix 1 in the LcrV structure [63].  A peptide comprising residues 31 to 
49, designated V7, was most active.  We tested the ability of the synthetic cognate 
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peptide based on the Y. pestis sequence, which differs at single residue (K43→N) from the 
homologous region in Y enterocolitica, to activate TLR2.  This peptide has identical 
residues at all of the positions established by Sing et al. to be required for TLR2 
activation [82].  As shown in Figure 1B, this peptide is unable to stimulate HEK293 cells 
stably transfected with both TLR2 and CD14. Sing et al. [82] observed only weak activity 
with a longer synthetic peptide comprising residues 31 to 66 of Y. pestis LcrV [71].  A 
peptide comprising residues 27 through 43, corresponding to the inactive peptide 
designated V5 by Sing et al. [70], was also found to be inactive. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Activation of TLR2 by 
rLcrV.   (A) HEK 293 cells stably 
transfected with vector alone 
(pcDNA3), TLR2 alone, or both 
TLR2 and CD14 were stimulated 
with 10 ng/ml LPS, 1 ng/ml P3C or 
500 ng/ml rLcrV as indicated for 18 
h.  Supernatants were assayed by 
capture ELISA for the presence of IL-
8 as an indicator of TLR2 activation. 
(B) HEK 293 cells stably transfected 
with both TLR2 and CD14 were 
stimulated with 100 ng/ml LPS, 100 
ng/ml P3C, 5 μg/ml rLcrV or 20 
μg/ml of the indicated synthetic 
peptide for 18 h.  Supernatants were 
assayed by capture ELISA for the 
presence of IL-8 as an indicator of 
TLR2 activation.  (C) The same cells 
as for panel B were transfected with 
an NF-κB luciferase reporter and 
stimulated with P3C, MALP2, rLcrV 
at the indicated concentrations for 18 
h.  Relative luciferase activity is 
shown.  Data shown are means from 
triplicate assays with error bars 
indicating ranges and are 
representative of at least three 
experiments. 
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Multimers of rLcrV in purified preparations.  It has been previously observed that in 
solution, rLcrV is not present in significant amounts in monomer form, but instead exists 
primarily as a mixture of dimers and tetramers [83].  Dimers can form through disulfide 
bonds between the single cysteine residue (C273) in each rLcrV molecule [63]. To 
determine the form(s) present in our rLcrV preparation, we analyzed samples by 
electrophoresis, gel filtration, and immunoblotting.  
As shown in Figure 2, the major band of rLcrV seen by PAGE under native conditions 
migrates at a rate expected of rLcrV tetramer, and also contains higher molecular weight 
forms. The addition of reducing agent results in migration consistent with dimer.  Under 
combined reducing and denaturing conditions, migration is consistent with monomer.  
Analysis by gel filtration on a calibrated Superose 12 column yields similar results 
(Figure 3).   In the absence of reducing agent, elution time of the two primary peaks is 
consistent with tetramer and dimer.  In the presence of glutathione, dimer forms the 
primary peak and the tetramer peak is dramatically reduced (Figure 3A, Inset). In some 
preparations, a small peak consistent with monomer was observed under reducing 
conditions, but in no case did we detect monomer without addition of glutathione to the 
elution buffer (data not shown).  We conclude that disulfide bond formation in necessary 
for the existence of stable tetramers, but not for stable dimers. 
Both native PAGE and gel filtration also revealed high molecular weight species (>200 
kDal).  These eluted near the void volume of the column during gel filtration. The 
integrated absorbance of this early peak was reduced only slightly in the presence of 
glutathione, indicating that its integrity is not dependent on disulfide bonds (Figure 3A, 
Inset).  The presence of rLcrV in these high molecular weight fractions was confirmed by 
 30
immunoblotting (Figure 3B, Inset).  Silver-stained SDS-PAGE gels showed only a single 
band consistent with rLcrV in these fractions (data not shown), indicating that rLcrV is 
the major protein component of this material.   
 
 
 
 
 
 
 
 
 
 
 
The high molecular weight species containing rLcrV is responsible for TLR2-
stimulating activity. To determine which form(s) of rLcrV contain TLR2stimulating 
activity, fractions from rLcrV preparations separated on Superose 12 were assayed for 
TLR2 stimulating activity (Figure 3). HEK293 cells stably transfected with TLR2 and 
CD14 were treated with a sample of each fraction, and IL-8 was measured as an indicator 
of TLR2 activation. Surprisingly, neither the dimer nor tetramer forms were able to 
stimulate TLR2.  Virtually all of the TLR2-stimulating activity was associated with the 
higher molecular weight fractions, which contained less than 10% of the total rLcrV 
protein.  The pattern of activity among fractions was remarkably consistent when 
Figure 2.  Analysis of rLcrV by PAGE. 
Lanes 1 and 8 contain molecular weight 
markers formulated for use in native gels, 
with their sizes in kDal indicate at left.  In 
the absence of SDS, DTT, and thermal 
denaturation, rLcrV migrates at a rate 
consistent with tetramer, with some dimer 
also present (lane 2).  Addition of DTT 
results in migration consistent with dimer 
(lane 4). The combination of DTT and 
denaturing conditions   results in migration 
consistent with monomer (lane 6). Lanes 
containing rLcrV were separated by an 
empty lane, as diffusion of DTT into 
adjacent lanes affected migration.   High 
molecular weight species greater than 200 kD are visible under native conditions when the 
gel is loaded with 5μg rLcrV (lane 9).   The bands are less distinct than usual for SDS-
PAGE because the buffers do not contain SDS, allowing some loss of detergent from the 
protein as it migrates. 
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independent preparations were compared, even when different cell disruption techniques 
(sonication versus French pressure cell) that yielded different proportion of dimer and 
tetramer, but a consistent proportion of high molecular weight material, were used 
(compare Figures 3A and B). 
 
Taken together, these results indicate that the TLR2 stimulating activity of our rLcrV 
resides in stable multimers or aggregates substantially larger than tetramer.  rLcrV is the 
major, and perhaps the only significant, protein component of this material.  However, 
the presence of non-protein components, or highly active protein components in low 
abundance, cannot be excluded.  It is also possible that the tetramer and lower-molecular 
weight forms have some stimulatory activity obscured by the tailing peaks of the higher-
activity fractions, but if so, this activity must be very weak.  
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Figure 3.  Analysis of rLcrV by gel filtration. (A). rLcrV purified from sonic extracts 
was separated on a calibrated Superose 12 column.  Elution profile (A280, solid line) of the 
primary peaks indicates that rLcrV dimer and tetramer are the major species present.  A 
high molecular peak, eluting near the void volume of the column, is also present.  The 
profile obtained when 1 mM glutathione is included in the column buffer is shown in the 
inset.  Note conversion of the tetramer peak to dimer, but retention of the high molecular 
weight fraction.  Samples of fractions were also assayed for TLR2 stimulating activity 
(?) as in Figure 1.  Note that this activity is associated almost exclusively with material 
eluting prior to rLcrV tetramer.  (B).  An independent preparation of rLcrV purified from 
extracts made via a French pressure cell was analyzed as in panel A.  This preparation 
contained a much higher proportion of tetramer, and a similar proportion of high 
molecular weight material.  Assay of fractions for TLR2 activating activity (?) again 
show the material eluting before tetramer to be most active.  The inset shows an 
immunoblot of selected fractions prepared from a standard SDS-PAGE gel and probed 
with an LcrV-specific monoclonal antibody.  The selected fractions are indicated by 
circled numerals.  Note that the high molecular weight fractions contain rLcrV. 
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Analysis of an alternative rLcrV construct.  Virtually all studies of the 
immunosuppressive properties of LcrV are based on recombinant constructs, with 
somewhat different structures.  For example, the parent rLcrV fusion protein utilized by 
Overheim et al. [72] differs from ours in two significant ways: it has an amino terminal 
decahistidyl domain as opposed to the hexahistidyl carboxy-terminal domain in our 
construct, and includes the native Y. pestis LcrV sequence with no other additions.  In 
contrast, our mature construct has three additional amino-terminal resides (tmv) that 
precede the native LcrV domain, and two additional carboxy-terminal residues (vd) 
which precede the added polyhistidine sequence.  To determine if our finding that TLR2 
stimulation is due to high molecular weight forms was the result of such differences, we 
purified and analyzed rLcrV produced by the construct of Overheim et. al. [72].  The 
results of these experiments are shown in Figure 4.  As was found with our construct, all 
of the TLR2 stimulating activity of this rLcrV form was associated with fractions having 
much shorter elution times than dimer and tetramer.  Also, in agreement with results 
obtained with our construct, almost all of the rLcrV is in the form of dimers and 
tetramers.  No monomer is present.  In fact, the preparation analyzed in Figure 4 
contained less high molecular weight material than we had observed with our construct, 
and its TLR2-stimulating activity was correspondingly lower (Compare Figure 4 and 
Figure 3, noting the differences in scaling on the IL-8 concentration axis.)   Thus, it 
appears that our basic observations are not sensitive to minor differences in rLcrV 
structure.    
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Figure 4. Analysis of an alternative rLcrV construct by gel filtration.  rLcrV 
produced by the prLcrV construct of Overheim et al. purified as described (see Materials 
and Methods) was analyzed in experiments parallel to those of Figure.  Note that the 
results are very similar, although the content of high molecular weight material is 
somewhat lower, as is the level of TLR2 stimulating activity of the corresponding 
fractions.  Analysis via immunoblotting as in Figure 3 confirmed the presence of rLcrV 
in the active fractions (data not shown). 
 
Infection of TLR2-/- mice. The interaction between Yersinia enterocolitica rLcrV and 
TLR2 is reported to result in an anti-inflammatory effect, including suppression of TNF 
and induction of interleukin-10 (IL-10) [69-71], leading to decreased macrophage 
activation.  During Y. enterocolitica infection, this mechanism is proposed to contribute 
to evasion of innate immunity. To address the potential relevance of this mechanism to 
plague, we compared the disease produced in wild type and TLR2-/- mice following 
subcutaneous (s.c.) infection with virulent Y. pestis.   A dose of 1000 CFU of Y. pestis 
strain KIM1001 was uniformly lethal for both C57BL/6 mice and C57BL/6 TLR2-/- mice, 
and no significant difference in mean time of survival was observed (Figure 5A).  Subtle 
differences in resistance are more readily observed at doses that do not cause complete 
mortality.  Accordingly, we conducted a second comparison using a dose of 100 CFU, 
again delivered s.c. (Figure 5B).  This dose yielded 80% mortality in both wild type and 
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TLR2-/- animals.  Again, no significant difference in mean time of survival between 
mouse genotypes was observed.   
 
Cytokine levels and bacterial load in mice infected with Y. pestis. To determine if 
cytokine induction during infection was influenced by the TLR2 status of infected mice, 
we measured the levels of IL-10, TNF, and IL-6 in the spleens of five mice of each 
genotype two days following i.v. infection with 1000 CFU of KIM1001. The number of 
bacteria present in the spleen at this time was also measured. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. TLR2 deficiency and 
survival of Y. pestis-infected mice. 
WT (?) and TLR2-/- (?) mice, 10 
animals per group, were infected s.c. 
with KIM1001. Survival was 
monitored for 14 days, and no deaths 
were observed beyond day 9.  (A).  
Dose 1000 CFU. Note that survival 
time is very similar (mean: WT = 
4.25, TLR2-/- = 5.25, p = 0.85).  The 
results shown are representative of 
three experiments.  (B)  Dose 100 
CFU.   At this lower dose, survival 
time is also very similar (mean: WT  
= 7.25, TLR2-/-  = 6.5, p = 0.75).  The 
experiment was performed once at 
this dose. (Note: The TLR-/- group in 
this experiment contained 11 mice.) 
f 
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Intravenous infection was used in this experiment because it results in essentially 
simultaneous infection of internal organs: with s.c. infection, the time of dissemination of 
the bacteria sometimes varies among the animals.  We observed no significant difference 
in levels of either IL-10 or the pro-inflammatory cytokines TNF or IL-6 (Figure 6, panels 
A, B, and C).  Although the difference in the level of TNF was not statistically 
significant, it was suggestive of a higher level in the TLR2 deficient mice.  Note that this 
is inverse to the result predicted by the immunosuppression hypothesis.  There was also 
no significant difference in bacterial titers within the spleens between the two genotypes 
(Figure 6, Panel D).   
 
 Inflammation at Foci of Infection:  If TLR2-dependent stimulation of IL-10 production 
makes an important contribution to inhibition of local inflammation, we would expect 
enhanced inflammation at foci of infection in TLR2-/- mice. This should be readily 
observable in the livers of infected mice, because there is little inflammatory response to 
wild type Y. pestis in this tissue [6, 68] and any enhancement of the inflammation can be 
readily detected.  Accordingly, we harvested livers from the mice used in the cytokine 
experiments described above and examined sections to determine the state of 
inflammation at foci of infection.  As shown in Panels E and F of Figure 6, sections from 
both mouse genotypes show focal bacterial masses largely devoid of inflammatory cells.  
No evidence of enhanced inflammation in TLR2-deficient animals was observed.  
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Figure 6. TLR2 deficiency has little effect during infection with Yersinia pestis.  WT 
and TLR2-/- mice were infected i.v. with 1000 CFU KIM1001.  Spleens and livers were 
harvested two days post-infection.   Spleens were homogenized and cytokine levels were 
quantified by capture ELISA of IL-10 (A) TNF (B) and IL-6 (C).  No significant 
differences were detected for any cytokine between genotypes, although the higher TNF 
levels in TLR2-/- mice were suggestive (p = 0.056).  Bacterial loads in the spleens of the 
two genotypes (D) were also similar (p = 0.2).   Liver sections from both genotypes 
stained with hematoxylin and eosin (E, WT; F, TLR2-/-) showed a pattern typical of Y. 
pestis infection in wild type mice.  Masses of bacteria occupy liver sinusoids with little 
sign of local inflammation (white arrows).  For reference, (G) shows a liver section from 
an uninfected WT control. 
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Discussion 
 
The major goal of this work was to examine the hypothesis that the interaction of 
LcrV and TLR2 contributes significantly to Y. pestis virulence, whether via the induction 
of IL-10 or by any other means.  Our finding that TLR2-deficient mice showed no 
difference in their response to fully virulent Y. pestis as compared with wild type mice 
strongly suggests that this interaction plays little if any role in plague.  It should be noted 
that the virulent Y. pestis/mouse infection model is a very sensitive one, in that specific 
genetic modifications of bacteria or mice often have large effects on virulence. For 
example, otherwise virulent mutants lacking the Pla protease [6, 32] and mutants with 
defects in iron acquisition [32] show an increase in LD50 of several orders of magnitude, 
as do strains modified to produce highly stimulatory LPS [84].  TLR4 deficient mice are 
highly susceptible to a strain producing stimulatory LPS, while wild type mice are highly 
resistant [84].  In both of these instances, reduced virulence (or enhanced resistance) was 
also associated with marked enhancement of inflammation at foci of infection.  Thus it is 
clear that experimental manipulations in this system do indeed have very large effects 
when they are related to functional differences in the interaction between the bacteria and 
host defenses.  Our failure to observe any indication of enhanced resistance, improved 
inflammatory response, or altered cytokine levels in TLR2 deficient mice must therefore 
be regarded as strong evidence that this receptor does not play a significant role in 
interactions contributing to virulence of Y. pestis during infection.  
The literature regarding the induction of IL-10 by the LcrV of the yersiniae 
presents a somewhat confusing picture.  Sing et al. report that specific residues are 
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required for induction IL-10 by LcrV of Yersinia enterocolitica, and that peptides 
containing these residues are effective inducers [70, 71].  However, they also find that a 
peptide from the cognate region of Y. pestis and Y. pseudotuberculosis LcrV has little 
activity [71].  On the other hand, Overheim et al. report that regions of LcrV entirely 
distinct from that defined by Sing et al. are required for IL-10 induction by Y. pestis 
LcrV. While Sing et al., provide evidence from a well-established in vivo model 
supporting a role for the TLR2/LcrV interaction during Y. enterocolitica infection [70, 
71], these results are unfortunately dependent on the mouse strain employed [85].  No 
similar evidence has been published previously regarding Y. pestis.  For this species, 
currently available in vivo data is indirect in that all the relevant experiments involve 
injection of mice with various forms of recombinant LcrV, followed by measurement of 
cytokine levels and/or challenge with LPS, attenuated Y. pestis, or other unrelated 
pathogens [68, 86].  
 
A variety of fusion proteins have been used to demonstrate the 
immunosuppressive properties of LcrV.  For example, Overheim et al. utilize a N-
terminal decahistidyl tag [72].  Motin et al. fuse a 34 kilodalton fragment of Protein A to 
the N-terminus of a truncated LcrV lacking the first 67 residues [87].  The three-
dimensional structure of LcrV was determined from a fusion protein containing five 
residues fused to an LcrV N-terminus beginning at residue 28 and a C-terminal addition 
of four residues plus a hexahistidyl tag [63].  This structure shows that both the N- and C-
termini are very flexible and are located near each other, external to one of the LcrV 
globular domains.  The flexibility and location of these termini is consistent with 
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tolerance for additions and deletions.  Thus, it is unlikely that the three-residue N-
terminal and the eight residue C-terminal additions -- the latter including a six residue 
His-tag -- present in our LcrV construct is less reflective of the properties of native LcrV 
than those employed by others.  Moreover, we have shown directly that the rLcrV protein 
of Overheim et al. [72] behaves similarly to our own.  It should be noted that the 
cytokine-inducing properties of native LcrV purified from Y. pestis or any other Yersinia 
species has not been studied. 
 
Our results with recombinant His-tagged Y. pestis LcrV are consistent with those 
of others in that we do observe stimulation of TLR2 in vitro.  However, we also show 
that the ability of this material to stimulate TLR2 is unexpectedly complex at the 
biochemical level.  The major forms of rLcrV in our preparations, dimer and tetramer, 
have no TLR2 stimulating activity.  Such activity is detected only in high molecular 
weight multimers or aggregates.  Although the data from experimental infections 
discussed above argues strongly against a role for this activity in Y. pestis virulence, we 
consider three alternative hypotheses regarding TLR2 stimulation by LcrV, one of which 
implies physiological significance.    
 
First, the stimulatory activity may result from the presence of a potent TLR2-
activating contaminant (e.g. a lipoprotein, lipopeptide, peptidoglycan, etc.) constituting a 
small proportion of the aggregate, and not from rLcrV per se.  Such contamination is both 
common in material purified from whole cell extracts and notoriously difficult to 
exclude.  TLR2 stimulating activity initially ascribed to what were thought to be highly 
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purified materials has later been shown to result from such contamination (for example, 
see [79, 88, 89].  There is no general method to ensure freedom from such contaminants 
in protein preparations.  Note that vulnerability to such contaminants is greatly increased 
when cells expressing a variety of Toll-like receptors, such as mouse macrophages are the 
targets of stimulation. 
 
A second possibility is that the stimulatory activity is indeed due to rLcrV in the 
aggregates/multimers, but that this material is non-physiological and an artifact of over-
expression and purification techniques.  The tendency of recombinant proteins expressed 
at high levels in E. coli to form high molecular aggregates is well established.  Exposure 
of mature rLcrV to cell extracts as occurs during purification could also be a critical to 
formation of the stimulatory material.  In Y. pestis the level of LcrV expression is much 
lower, and exposure of mature LcrV to concentrated cell extracts does not occur.  In this 
view, the stimulatory aggregates/multimers are purely an in vitro artifact and have no 
physiologic relevance.  
 
A third possibility is that the stimulatory fractions contain structures that are, or 
resemble, physiological multimeric species that are normally detected by TLR2 as an 
indicator of pathogens with T3SS machinery.  A study by Broz et al. demonstrated by 
scanning transmission electron microscopy (STEM) and quantitative immunoblotting that 
three to five monomers of LcrV form each tip complex of a needle {Broz, 2007 #240}.  
Perhaps such structures are occasionally released from bacteria in vivo and elicit pro-
inflammatory responses via TLR2.  However, there is no evidence to support this idea 
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from infection experiments with yersiniae.  Also, PcrV, a related protein from 
Pseudomonas aeruginosa, does not stimulate TLR2 [70]. 
 
The association of TLR2 stimulation with aggregates/mutimers of rLcrV suggests 
that individual rLcrV molecules may interact weakly with TLR2 and that activation 
results from clustering of the receptor {Triantafilou, 2004 #241}.  This would explain the 
failure of low molecular weight forms to cause activation.  Other groups have not 
reported the molecular size of the active fraction in their recombinant LcrV preparations 
under non-denaturing conditions.  Consequently, the presence of a similar stimulatory 
high molecular weight aggregate in their experiments cannot be excluded.  The specific 
activity of our preparations is similar to that reported by others: if the activity they 
observe is not due to aggregates, which we find to constitute a small fraction of total 
protein, then the activity of rLcrV in their preparations on a per molecule basis must be 
correspondingly low.  The clustering hypothesis suggests that rather than disrupting a 
specific TLR2/LcrV interaction, mutations which give rise to inactive recombinant LcrV 
preparations may interfere with formation of aggregates capable of activating TLR2.  
 
Overheim et al. (22) have presented data suggesting that LcrV deletion mutants 
failing to stimulate IL-10 production are more effective immunogens, presumably due to 
the elimination of immunosuppressive activity.  Our results show that highly purified 
LcrV preparations containing only dimer and/or tetramer lack TLR2 stimulating activity 
and hence may also have improved performance in vaccine applications.  However, we 
have previously shown that, with DNA vaccines, production of LcrV multimers in vivo 
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was critical to providing an effective protective response, and also biased the response 
toward TH1 as compared with the response produce by constructs producing only rLcrV 
monomer [46].  While we do not know the extent of multimerization occurring in vivo, 
the association of multimerization with TLR2 stimulation suggests the possibility that 
large multimers form in vivo and provide adjuvant activity in the context of the live 
vaccine through stimulation of TLR2, rather than immunosuppression.  This adjuvant 
effect is more consistent with current understanding of TLR2, function than is an 
immunosuppressive effect.       
 
In summary, our investigation provides no support for the hypothesis that 
activation of TLR2 by LcrV contributes to the virulence of Y. pestis via 
immunomodulation.  In a sensitive infection model using virulent Y. pestis, elimination of 
TLR2 has no effect on the course of disease, or on cytokine levels observed in vivo.  The 
bulk of recombinant LcrV protein has no TLR2 stimulating activity in vitro, and such 
activity is restricted to high molecular weight aggregates/multimers that contain LcrV but 
are of undetermined composition.  Given the well-established sensitivity of the Y. pestis 
mouse infection model, its lack of response to TLR2 deficiency must be regarded as 
strong evidence that TLR2-induced immunomodulation does not have a significant role 
in plague. The early observations suggesting a direct immunosuppressive role for LcrV 
were based on direct injection of recombinant LcrV preparations into mice resulting in 
immunosuppression and elevated levels of IL-10 [86].  A TLR2-independent mechanism 
of IL-10 induction would be consistent with these early observations.  However, the 
levels of IL-10 we observed in infected mice are modest (~1 ng/g of spleen, 1/10 the 
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level associated with induction by Sing et al.. [71] and hence not consistent with this 
hypothesis.   
 
Detailed infection experiments have also been conducted using strains of Yersinia 
enterocolitica and Yersinia pseudotuberculosis by Victoria Auerbuch et al.  They also 
observed no differences in the course or pattern of disease, or in cytokine levels, between 
TLR2-sufficient and deficient mice.  The conflicting results of Sing et al.. imply that 
LcrV/TLR2-mediated immunosuppression may operate under certain limited 
circumstances (i.e. with specific combinations of Y. enterocolitica strains and mouse 
strains), but, given the present weight of evidence, it is unlikely to be a phenomenon of 
general importance to virulence in the yersiniae. 
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Addendum 
 Subsequent to the acceptance of this manuscript, additional data related to this 
work has been published. A study by Reithmeier-Rost et al. demonstrate that preparation 
of an untagged rLcrV from the Y. enterocolitica strain O:8 was  able to stimulate mouse 
bone marrow derived macrophages (BMDM) significantly better than an untagged rLcrV 
from Yersinia pestis [90].   They observed approximately five-fold better induction of 
both TNF and IL-10 by Y. enterocolitica rLcrV compared to Y. pestis rLcrV.  In vivo 
experiments show no significant difference in the survival of TLR2-/- mice compared to 
wildtype after subcutaneous challenge with the virulent Y. pestis strain, GB. They 
conclude that the low stimulatory activity of Y. pestis rLcrV compared to Y. 
enterocolitica they observe explains the survival of TLR2-/- mice, results consistent with 
our own.  Binding studies by Abramov et al. show that LcrV peptides derived from Y. 
pestis are not only able to interact with human TLR2 but also with IFN-γ receptor [91].  
Their data indicate that LcrV peptides comprising LEEL32-35 and DEEI 203-205 are able to 
bind free TLR2 and human IFN-γ receptor.  Neither of these peptides contains the 
required KDKN sequence recognized by Sing et al. to bind TLR2.  We conclude that this 
interaction, if it occurs in vivo, does not seem to be biologically relevant as two 
independent groups, using strains from two Y. pestis biotypes, have shown no difference 
in survival between wildtype and TLR2-/- mice. 
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Chapter Three. 
A Brief Review of Natural and Experimental  
 
Transmission of Y. pestis 
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Bubonic and septicemic plague, resulting from transmission of Yersinia pestis by 
fleas, are the most common forms of Y. pestis infection.  Bubonic plague is characterized 
by the presence of grossly enlarged lymph nodes in conjunction with systemic infection, 
while septicemic plague is characterized by septicemia in the absence of buboes.  This 
difference reflects more immediate access of the bacteria to the bloodstream in the case 
of septicemic plague, resulting in the appearance of symptoms prior to the appearance of 
buboes. Of thirteen cases of plague in the United States in 2006, five patients had primary 
septicemic plague and the remaining eight had bubonic plague [92].  
 
The most severe form of the disease, with a mortality rate of 100% when 
untreated, is Y. pestis pneumonia, known as pneumonic plague.  Pneumonic plague may 
occur secondarily to bubonic or septicemic plague.  When patients present with severe Y. 
pestis pneumonia and no indication of bubonic plague, the disease is classified as primary 
pneumonic plague.   In 2005, the World Health Organization (WHO) reported 57 deaths 
resulting from primary pneumonic plague in a group of diamond miners in the 
Democratic Republic of the Congo (DRC) [93].  One of the largest recorded outbreaks of 
pneumonic plague occurred in Manchuria during 1910-1911 with an estimated 50,000 
fatalities [94].   
 
Coughing generates both small and large aerosolized respiratory droplets that can 
have a diameter of up to 100 microns.  Evaporation of these small droplets results in 
droplet nuclei, having a diameter of only 2 to 20 microns {Wells, 1946 #238}.  While 
inhalation of aerosols containing Y. pestis into the lungs is generally assumed to be the 
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cause of primary pneumonic plague and can certainly cause the disease, several 
observations suggest that such direct infection of the lungs may not be the usual mode of 
human-to-human transmission.  First, transmission of pneumonic plague appears to occur 
via droplets rather than droplet nuclei, suggesting that direct penetration to the deep lung 
is unlikely.  The infected droplets appear to be relatively large, as they are only detected 
within close proximity (1m) of infected patients {Wu, 1926 #107}.  Secondly, Y. pestis 
readily colonizes the nasopharynx and upper airways, where large droplets are more 
likely to be deposited {Tang, 2006 #239}.  These observations suggest to us that 
penetration to the lung is very likely secondary to asymptomatic or mildly symptomatic 
nasopharyngeal colonization.  
 
 Failure of the bacteria to reach the lung during the early stages of nasopharyngeal 
disease would result in progression to frank plague pharyngitis with the potential for 
systemic spread and the formation of cervical buboes, a rare but established form of 
disease.  In a sense, this relationship is parallel to that of septicemic and bubonic plague 
to transmission via flea bite: in both cases, colonization via one route of transmission 
gives rise to two distinct forms of disease depending on dissemination to secondary sites.  
The rarity of nasopharyngeal plague suggests that penetration to the lungs following 
colonization is quite efficient.  
 
It is also possible that nasopharyngeal colonization plays an important role in 
plague transmission among mammalian hosts in nature.  In an attempt to mimic 
transmission between rodents in nature, studies by Rust et al. were able to sustain 
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transmission for an extended period among mice allowed to eat the carcasses of cage 
mates having died of plague.  Rust et al. also found that all animals either fed infected 
carcasses or that consumed food infected with Y. pestis died within five days of 
consumption [59].   However, none of the ten rats challenged with infectious material by 
direct intubation of the stomach succumbed to plague.  They conclude that all animals 
succumbed to terminal bacteremia and observed significant pathology in either the 
bronchial or mediastinal lymph nodes.  In addition, they suggest that bacteria gained 
entrance through the pharyngeal mucosa [59].   
   
The majority of work on progression and kinetics of plague has focused on the 
bubonic and septicemic forms of the disease.  Intradermal inoculation of small numbers 
of wildtype Y. pestis results in a rapidly spreading systemic infection.  Studies 
demonstrate that the absence of the pgm locus, absence of the type three secretion system 
in toto or many of its individual components, or the absence of the Pla protease results in 
a significant decrease in virulence [15].   For example, the loss of Pla causes up to a 
million-fold increase in the LD50 for subcutaneous infection, but no difference in 
virulence is observed when mice are infected intravenously [6].  Y. pestis also causes 
systemic disease when infection occurs by other routes.  Hematogenous dissemination of 
Y. pestis from the lungs in pneumonic plague is well established.  Less attention has been 
given to septicemia following oropharyngeal infection, although the literature contains 
sufficient data that this does occur. Although many researchers recognize the ability of Y. 
pestis to disseminate from the oral mucosa to the bloodstream, the mechanism by which 
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this occurs is not understood [59, 95].  Most in vivo studies of pneumonic plague have 
focused on protective vaccines or antibiotic therapies [47-49, 96-98].   
 
In a study by Davis et al., all twenty-one African Green monkeys infected with Y. 
pestis via aerosol succumbed to primary pneumonic plague within ten days [42].  In all 
cases, examination of the lungs revealed multilobar pneumonia, pleural effusion, and 
fluid in the airways, similar to that observed in human pneumonic plague. Interestingly, 
bacteria and inflammation observed in the larynx and tracheal submucosa was associated 
with the mucosa-associated lymphoid tissue (MALT).  The authors speculate that this 
may be the site where bacteria enter the bloodstream, and argue that further investigation 
of the mucosa-associated lymphoid tissue as a site for bacterial entry is warranted.   
 
Aerosol or intranasal infection of mice results in a similar pathology; intranasal 
infection of BALB/c mice with 5 x 103 wildtype organisms resulted in death of all 
animals between days 3 and 5.  Monitoring of peripheral organs during the experiment 
reveals the bacterial burden reaching 106 in the spleen and liver by day two, and 108 
organisms in the lung.   Little inflammation was noted in the lung until after bacteria had 
disseminated to peripheral sites.  The authors note that the presence of bacilli in 
macrophages may indicate a vehicle by which they travel [99].  
 
Butler et al. observed that six hours after ingestion, bacteria were recovered from 
the spleens of rodents, but not from the Peyer’s patches or mesenteric lymph nodes 
(MLN) [95].  No pathology was observed in the lungs of any rodents, suggesting that 
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bacteria were not aspirated during oral challenge causing primary pneumonic plague.  
Previous studies have shown that reducing the normal intestinal flora with antibiotic 
treatment or reducing stomach acidity with bicarbonate increases the susceptibility of 
animals to enteric infection by other pathogens [100 {Knop, 1975 #228, 101].  In this 
study, there was no difference in Y. pestis infectivity observed between control animals 
and animals either intragastrically-administered streptomycin or sodium bicarbonate, 
suggesting to the authors that bacteria are rapidly absorbed in the gut or that Y. pestis 
cannot survive in an environment changed by the reduced number of normal intestinal 
flora.   Interestingly, unlike the conclusions of Rust et al., the authors never suggest any 
involvement of the naso-pharyngeal area as a portal of entry for bacteria.  An alternative 
and perhaps simpler interpretation of these results is that bacteria responsible for systemic 
infection never reach the stomach; instead they penetrate mucosal barriers in the upper 
alimentary tract. 
 
These studies as well as cases of pharyngeal plague in humans suggest Y. pestis is 
able to traverse epithelial barriers within the lung and/or upper airways, however, a 
mechanism whereby bacteria cross these barriers has not been conclusively demonstrated 
in vivo.  There are several possible mechanisms where traversal of the epithelial barrier 
could occur: direct destruction of the epithelia by type three secreted effectors, damage 
caused by inflammation or the direct invasion of epithelial cells followed by penetration 
across the epithelial layer.  In Chapter Four of this work, we investigated the biological 
relevance of invasion during pneumonic transmission; and in Chapter Five we addressed 
virulence factors and their regulation involved in this process. 
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Chapter Four. 
Enhanced Invasion by Yersinia pestis 
at Atmospheric Oxygen Levels 
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Introduction 
 
Colonization of epithelium by bacterial pathogens often involves adhesion to or 
invasion of epithelial cells, and it has been known for some time that Y. pestis has both 
these abilities [41, 60].  However, adhesion and invasion have never been convincingly 
connected with Y. pestis virulence, and in vitro studies have suggested that such a role is 
unlikely because an abundant surface protein, known as F1 (or Caf1), interferes with 
these functions through inhibition of cell-cell contact [41]. 
 
  F1 has been historically described as a capsular antigen because it forms a 
substantial layer around the bacteria, but its structure and properties differ greatly from 
classical polysaccharide capsules.  The F1 protein is a typical chaperone-usher pilin 
which self-assembles to form pili-like structures of varying length only loosely associated 
with the bacteria surface.  The caf operon, which encodes the pilin, usher, and chaperone, 
is strongly regulated by temperature, although the mechanism is not known. It is not 
expressed at 30°C, but strongly expressed at 37°C.  Because expression of F1 has been 
shown to block both adhesion and invasion in vitro, only caf mutants of Y. pestis have 
been shown to be invasive to mammalian cells in culture when grown at 37°C in liquid 
medium [41] 
  
Growth conditions for Y. pestis used in mouse infection experiments vary widely 
among investigators.  To avoid the risk of aerosol generation when preparing inocula for 
infection studies, we typically grow the bacteria on solid media under ambient oxygen 
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conditions.  We generally incubate at 26°C, similar to the temperature within fleas, for 
subcutaneous infection studies, and at 37°C for pulmonary infection studies.  Infection 
experiments conducted by investigators at United States Army Research Institute for 
Infectious Disease (USAMRIID) use fully virulent Y. pestis strains grown on agar slants 
for s.c. experiments, but bacteria grown in shaking liquid culture for aerosol infection, 
always grown at 30°C [42].  Moreover, almost all in vitro studies of the interaction Y. 
pestis with mammalian cells, including our own, have been conducted with attenuated Y. 
pestis strains grown in shaking liquid cultures [41, 60]  To determine if these differences 
in growth conditions might affect behavior of the bacteria, we conducted parallel in vitro 
interaction experiments with mammalian cells and Y. pestis grown on both solid media 
and in aerated liquid cultures.  Surprisingly, bacteria grown on solid medium in a 
standard air incubator at 37°C proved to be much more invasive than those grown in 
shaking liquid cultures when incubated at 37°C.   
 
Because this observation has potential implications for both in vitro studies of Y. 
pestis/mammalian cell interactions and for behavior of the bacteria in the upper airways 
where oxygen concentrations at the epithelial surface are high, we investigated the basis 
of this effect and found that atmospheric oxygen levels suppress F1 production.  
 
We also examined the influence of growth at atmospheric oxygen levels on 
disease following upper respiratory inoculation of mice.  Contrary to our hypothesis 
based on these in vitro observations, preliminary results of in vivo experiments clearly 
indicate that bacteria grown under microaerophilic conditions, which induce F1 
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production, are more virulent via low-volume intranasal infection than bacteria grown at 
atmospheric oxygen levels.  Furthermore, we show that bacteria are unable to survive for 
an extended period of time in an intracellular environment in vitro. 
 
Material and Methods 
 
Bacterial strains and growth conditions. The bacterial strains and plasmids used in this 
study are listed in Table 2. For liquid-grown Yersinia pestis, strains were grown in TB 
medium containing 10 g Bacto-tryptose, 5 g NaCl, 3 g Beef Extract (paste form, Difco 
Cat # 212610) per liter supplemented with 2.5 mM CaCl overnight at 30°C or 37°C 
where indicated. For growth of solid-grown Yersinia pestis, 5 x 106 CFU were inoculated 
as a thin film and grown on TB medium supplemented with 2.5 mM CaCl and 15 g per 
liter agar for 16 hours at 28°C or 37°C where indicated.  For growth of bacteria under a 
reduced oxygen environment, bacteria were inoculated onto TB agar as described above 
and incubated in an unvented polycarbonate jar (BBL) with a CampyPak™ Plus 
Microaerophillic System envelope (BBL).  Escherichia coli strains were grown in Luria-
Bertani broth or on Luria-Bertani agar at 37°C.  MC4100pJL272 expressing invasin 
(inv+) and MC4100pRI203::TnphoA (inv-) were grown in LB media supplemented with 
100μg/ml ampicillin (kind gift of John Leong, University of Massachusetts). β2155 was 
grown in LB media supplemented with 50μg/ml diaminopimelic acid, DAP (Sigma). 
 
Cell Lines and Tissue Culture Reagents. .  The type I human alveolar epithelial cell 
line, WI26 (American Type Tissue Collection, MD) was maintained in Minimum 
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Essential Medium (Invitrogen) supplemented with 10% heat-inactivated fetal bovine 
serum (Invitrogen) and 10μg/ml Penicillin/Streptomycin (Invitrogen).  HeLa human 
epithelioid cells were maintained in Dulbecco’s modified Eagle’s Medium (Invitrogen) 
supplemented with 10% heat-inactivated fetal bovine serum and 10μg/ml 
Penicillin/Streptomycin. All cell lines were maintained at 37°C with 5% CO2. 
 
Cell Invasion.  Cells were seeded at 5 x 104 per well in 24-well tissue culture dishes 
(Costar) and grown overnight at 37°C with 5% CO2.  The day of the experiment, cells 
were washed twice with warm, serum-free RPMI 1640 (Invitrogen).  For liquid grown 
bacteria, cell were pelleted and washed once with phosphate-buffered saline (PBS, 135 
mM NaCl, 2.68 mM KCl, 10 mM NaHPO4, 1.76 mM KH2PO4), and resuspended in PBS.  
For solid-grown Y. pestis, cells were washed off plates with a small volume of sterile 
water and resuspended in PBS. Bacteria were diluted into warm serum-free RPMI 1640 
at a concentration of 106 CFU/ml.  Warm medium was removed from the cells and one 
milliliter of the bacterial suspension was added to give a multiplicity of infection (MOI) 
of 10.   Tissue culture dishes were then centrifuged for 10 minutes at 182 x g at room 
temperature and incubated for one hour at 37°C with 5% CO2.  Cells were washed as 
above and extracellular bacteria were killed by the addition of 50 μg/mL gentamycin in 
serum-free RPMI 1640 for one hour at 37°C with 5% CO2.  Cells were washed with 
RPMI and one milliliter of ice cold water was added to lyse cells.  Dishes were placed on 
ice for 10 minutes and numbers of intracellular bacteria were determined by serial 
dilutions of the lysate.  All experiments were done in triplicate wells in at least three 
independent experiments.  The final inoculum was verified by CFU determination.   For 
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cell invasion experiments extending over an hour, cells were infected and treated with 
gentamycin as above, were washed extensively and then incubated with serum-free RPMI 
for the duration of experiment to exclude the possibility of gentamycin leaking into the 
cell and killing intracellular bacteria.  Intracellular bacteria were quantified as above. 
 
Microscopy.  Duplicate 24-well tissue culture plates (Costar) were seeded with 5 x 104 
cells per well. To assess invasion efficiency, one set of samples was subjected to a 
standard gentamycin protection.  For electron microscopy, WI26 cells were infected as 
described above, washed three times with serum-free RPMI, and then fixed by incubating 
overnight in 2.5% glutaldehyde in 0.05% sodium phosphate buffer pH 7.2 at 4°C.  
Monolayers were washed twice with 0.1M sodium phosphate buffer at 4°C and then 
treated with 1% osmium tetroxide in sodium phosphate buffer for one hour at room 
temperature.  Osmium was washed from the cells with two washes of sterile water for 20 
minutes at 4°C.  Cells were dehydrated with a series of increasing ethanol concentrations 
from 10% to 100%.   Propylene oxide (100%) was added and then cells were infiltrated 
with Spurr’s resin mixture overnight at room temperature.  The next day, fresh resin was 
added three times for one hour.  Samples were placed in an oven and allowed to 
polymerize for 48 hrs at 60°C. 
  
Construction of Yersinia pestis mutants.  The Δcaf1 mutant was constructed by allelic 
exchange as described in Edwards et al. [102].  Two DNA fragments of ca. 1-kb flanking 
the caf1 locus were amplified from KIM6 by colony PCR using the primer pair  5” ATC 
GAT GGT ACC CTT CCA GTA TCA GTG GGT TC 3’ and 5’ TGC TGC TGC TGC 
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TGC GTA ACC GTA TCT AAC CAA TAA 3’ for the upstream fragment and the primer 
pair 5’ GCA GCA GCA GCA GCA TGG CGA TAA CGG AAC TGA T 3’ and 5’ ATC 
GAT GAG CTC CGT GAC AGT AGG AGC ACA ACT T 3’ for the downstream 
fragment.  These two fragments were joined by PCR to produce a 2-kb amplicon with a 
central unique restriction site, MluI.  The flanking and restriction sites were used to clone 
the resulting amplicon into the corresponding sites of pRE107 (generous gift of D. 
Schifferli, University of Pennsylvania) to generate pK101.   To delete caf1 from Y. pestis, 
pK101 was electroporated into β2155 (50μl, 109 CFU) cells with 2000 volts using an E. 
coli TransPorator (BTX).  Cells were allowed to recover for 2 hours in LB broth 
supplemented with 50μg/ml DAP at 37°C.  Bacteria were plated onto LB agar 
supplemented with 50μg/ml DAP and 50μg/ml ampicillin to select for transformants.  
For matings, β2155 pK101 and Y. pestis cells were mixed at a high density and were 
grown on TB agar supplemented with 50μg/ml DAP overnight at 30°C.  To select for Y. 
pestis clones with integrated plasmids, dilutions of the mating mixture were plated on TB 
with 50μg/ml ampicillin and grown overnight at 30°C.   Isolates were selected for sucrose 
resistance on TB supplemented with 5% sucrose and screened for ampicillin sensitivity to 
confirm plasmid loss.  The caf1 deletion mutant was confirmed by PCR and F1-specific 
immunoblotting.   
 
Two additional strains were also constructed for potential use as readily distinguishable 
competitors in infection experiments.  KIM1001ΔxylB was created by allelic exchange 
using plasmid, pGK01ΔxylB (generous gift of B. Akerley), using methods described 
above.  This mutation was confirmed by growth on MacConkey agar (Difco) 
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supplemented with 1% xylose.  For creation of nalidixic acid resistant Y. pestis, a high 
density of KIM1001 were grown on ten TB agar plates containing 50 μg/ml nalidixic 
acid.  Resistant clones were confirmed by streaking single colonies onto TB 
supplemented with containing 50 μg/ml nalidixic acid.  
 
Antibodies.   Mouse anti-F1 monoclonal antibodies (clone VA18) were purchased from 
Meridian Life Sciences (formally Biodesign). Polyclonal anti-Pla antibodies were 
produced by injecting rabbits with E. coli over-expressing Pla and purified by ammonium 
sulfate precipitation followed by adsorption to a Pla-deficient Y. pestis strain. Alkaline 
phosphatase conjugated anti-mouse and anti-rabbit IgG were purchased from Sigma. 
 
SDS-PAGE and Immunolotting.   Total protein extracts from 5 x 106 Y. pestis cells 
were run on SDS-PAGE (10% acrylamide) (Biorad) at 100V for 1 hour. For 
immunoblotting, proteins were transferred to a PVDF membrane (Millipore) for 1 hour at 
100V. Membranes were blocked overnight in 5% nonfat milk in PBS (PBSM) at 4°C.  
Membranes were incubated with primary antibody diluted in 5% PBSM at room 
temperature with agitation for two hours.  After three washes for 5 minutes each in 
PBS/0.1% Tween, membranes were incubated with secondary antibody diluted in 5% 
PBSM at room temperature with agitation for two hours. After three washes for 5 
minutes each in PBS/0.1% Tween, membranes were washed for 20 minutes with high pH 
Tris buffer (100 mM Tris Buffer, 100 mM NaCl, 5 mM MgCl2 pH 9.5) and developed 
with 0.005% 5-Bromo-4-Chloro-3-indolyl phosphate (BCIP)  (Sigma) and 0.005% nitro 
blue tetrazolium resuspended in high pH Tris Buffer. 
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Mice.  Female C57BL/6 (6-8 weeks of age) were purchased from Jackson Laboratory 
(Bar Harbor, Maine).  All mice were bred under specific-pathogen-free conditions. All 
animal studies were approved by the Univ. of Massachusetts Medical School Institutional 
Animal Care and Use Committee and all relevant policies regarding animal care, 
biosafety, and security were followed.  
 
Experimental Infection of Mice. To prepare inocula for experimental infection, the 
strains to be used were inoculated onto TB plates from suspensions stored at –70°C in TB 
(no agar) plus 5% glycerol, and incubated at 28°C for 24 hours.  Suspensions from these 
plates were made in sterile water, and one hundred microliters of the suspension was 
spread evenly onto two agar plates of solid TB media using a sterile spreader.  Bacteria 
were grown for 16 hours at 37°C under either atmospheric levels of oxygen or within a 
microaerophillic chamber as described above.  Bacteria were harvested from the plate 
with a loop and resuspended in sterile distilled water with a vortex mixer to match a 
turbidity standard of OD600 0.35.  It was important to use low ionic strength medium for 
this initial suspension step to achieve good dispersion of the cells.  This initial high 
density suspension was subsequently diluted as required using endotoxin free injection 
grade PBS (Cambrex).   Anesthetized mice (ketamine 26.7 mg/ml and xylazine 6.7 
mg/ml) 50 μl i.p. were infected intranasally as in Iyer et al. with the indicated dose of 
KIM1001 pBR322 Δtet in a total volume of 4 μl [103]. Two 1 μl drops were 
administered to each nostril.  Mice were monitored for 7 days. 
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Results 
 
Growth of bacteria in liquid at 37°C inhibits invasion 
  
 Several groups have shown that growth of Yersinia pestis at 37°C significantly 
inhibits invasion in vitro {Cowan, 2000 #42{Liu, 2006 #45}}.   Mouse infection studies 
conducted by other groups typically use bacteria grown in liquid culture at 30°C or 37°C.  
We wanted to determine both quantitatively and qualitatively the invasion efficiency of 
Y. pestis grown at 30°C or 37°C.  We conducted invasion experiments at both 
temperatures with both pPCP1-sufficient and deficient bacteria, as original observations 
of Cowan et al. indicated that the presence of pPCP1 enhances invasion.  In order to 
visualize interactions between Yersinia pestis and cultured epithelial cells, electron 
microscopy images were prepared from infected HeLa and WI26 cells. Cell monolayers 
were inoculated with 106 CFU/well of each bacterial strain and incubated for one hour at 
37°C. As shown in Figure 7, adherent bacteria and bacteria being engulfed by cell 
membrane were visualized in samples infected with either MC4100pJL272 (Panel A) or 
30°C-grown KIM6 (Panel B).  Virtually no bacteria were seen in MC4100pTn::phoA inv- 
infected monolayers, and significantly less adherent bacteria were visualized in 37°C-
grown KIM6 (Panel C) or JG154 (Panel C, inset) infected monolayers.  We were able to 
visualize both adherent and intracellular bacteria, in addition to interesting cell membrane 
projections and ruffling.  In an experiment using HeLa cells, we also were able to 
visualize by electron microscopy intracellular and adherent Y. pestis as well as MC4100 
pJL272 (data not shown).  When we quantified numbers of bacteria from a duplicate 
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experiment, we found significantly less invasion by 37°C grown and pPCP1- Y. pestis 
when grown in liquid culture.   
 
 30°C 
HeLa 
 
 37°C 
 
 
 
WI26 
 
 
 
 
 
Figure 7.  Y. pestis grown in liquid culture at 37°C inhibits invasion as shown by gentamycin 
protection assay and as visualized by electron microscopy (EM) .  HeLa  (top) and WI26 
(bottom) cells were seeded in 24-well tissue culture plates at 5 x 104 cells per well.  The next day, 
triplicate wells were infected for an hour with pPCP1+ or with pPCP1- Y. pestis grown in liquid 
medium at 30°C (HeLa, WI26) or 37°C (WI26). To determine the assay efficiency, triplicate 
wells were infected with MC4100pJL272 (G, J) or with the vector control (not shown).  After 
extensive washing, monolayers were incubated at 37°C with 50 μg/ml gentamycin for an hour.   
For visualization by EM, monolayers were prepared as described in the Materials and Methods.  
Adherent and internalized Y. pestis was observed in both HeLa (A-F) and WI26 cells (H, K).  
Significantly less adherent 37°C-grown bacteria were observed compared to 30°C-grown bacteria 
(compare H and K to I).  Consistent with results by Cowan et al., the presence of pPCP1 
enhanced invasion (compare H and K to L). 
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Enhanced Invasion of WI26 cells by Yersinia pestis grown under conditions of high 
O2 availability 
 
 When preparing inocula for animal infection experiments, we typically grow the 
bacteria on solid TB medium in Petri dishes under ambient atmospheric conditions at 
37°C.  We asked whether bacteria grown in this way were similarly invasive compared 
with bacteria grown in aerated liquid cultures at 37°C. Growth rate experiments were first 
conducted to determine the time to log phase growth of solid-grown bacteria.  Bacteria 
were grown as a thin film on solid TB media and 0.785 cm2 samples were extracted at 
regular intervals and total bacteria was determined by dilution and plating.  We 
established log phase growth of a inoculum of 5 x 106 colony forming units (CFU) on 
solid media to persist ca. 16 hours for both 30°C and 37°C grown Y. pestis. 
 
We compared the invasive capacity of liquid- versus solid-grown Y. pestis at 
37°C.  We were surprised to discover that bacteria grown on solid media at 37°C exposed 
to an air interface retained significantly greater invasive capacity in the human lung-
derived epithelial cell line, WI26, as quantified by gentamycin protection assay than 
those grown in liquid culture at the same temperature (Figure 8).  We hypothesized that 
bacteria that were exposed to atmospheric levels of oxygen on solid media were 
responsible for the difference in invasive capacity that we observed.  To address this 
question we utilized a microaerophillic chamber, lowering the available oxygen to 
approximately half atmospheric levels. Bacteria were grown on solid media at 37°C 
exposed to either an air interface or were incubated within the microaerophilic chamber.  
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As shown by Figure 9, invasive capacity was subsequently lost when bacteria were 
grown in the microaerophillic chamber. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and intracellular bacteria were quantified by dilution plating on TB. Assays were 
conducted in triplicate wells in at least three separate experiments.  MC4100 pJL272 
(inv+) and MC4100 pRI203::TnphoA (inv-) are included as controls and are used in 
subsequent gentamycin protection assays to determine assay efficiency (inset).  ** p < 
0.005 (solid vs. liquid at 37°C). 
 
To confirm that retention of invasive capacity during growth at 37°C was dependent on 
oxygen availability, not on an increase in carbon dioxide production, we also conducted 
gentamycin protection assays with bacteria grown in liquid cultures under a gradient of 
aeration regimes achieved by various volumes of medium in shaken culture flasks of 
identical size.  This method has previously been utilized to show differential expression 
of virulence factors in Haemophilus influenzae. 
  
 
 
Figure 8.  Enhanced invasion of 
WI26 cells by Y. pestis grown at an 
air interface.  KIM6 (pgm- pCD1-) 
was grown at 30°C or at 37°C in TB 
in a culture tube that was incubated 
for 16 h on a standard roller drum 
(liquid); or as a thin film on tryptic 
blood agar under atmospheric oxygen 
conditions (solid). Bacteria were 
washed with PBS and resuspended in 
serum-free RPMI at an MOI of 10 
and were centrifuged onto a 
monolayer of WI26 cells and 
incubated for an hour at 37°C with 
5% CO2. After three washes with 
serum free RPMI, gentamycin 
(50μl/ml) was added for an hour at 
37°C with  5%  CO2.  WI26 cells 
were lysed with 1 ml ice cold water   
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As shown in Figure 10, high invasive capacity was attained only under the most vigorous 
aeration condition, in which the medium occupied 2% of the culture flask capacity.  This 
result was independent on the presence of pPCP1 and is consistent with a requirement for 
very high oxygen levels for development of invasive capacity during 37°C growth. 
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Figure 9.  Low oxygen conditions 
inhibit high efficiency invasion. KIM6 
(pgm- pCD1-) was grown at 30°C or at 
37°C as a thin film on TB agar under 
atmospheric oxygen conditions (air) or 
within a microaerophillic (MA) chamber.   
A standard gentamycin protection assay 
was conducted using WI26 cells as in 
Figure 8 with samples of Y. pestis grown 
under conditions described above. Assays 
were conducted in triplicate wells in at 
least three separate experiments.  
MC4100 pJL272 (inv+) and MC4100 
pRI203:: TnphoA (inv-) (inset).   
**p < 0.005.    
Figure 10. Requirement for high 
oxygen levels for efficient invasion 
during 37°C growth in liquid culture. 
KIM5 (pgm-) and JG153 ((pgm- pPCP1-) 
were incubated in 500 mL shaking flasks 
(250 rpm) in 10 mL, 60 mL or 200 mL 
volumes of trypic blood agar base 
without agar to log phase.  Samples of 
bacteria were used for a standard 
gentamycin protection assay as described 
in Figure 7.  Similar results were 
obtained with pCD1- bacteria. Assays 
were conducted in triplicate wells in at 
least three separate experiments. MC4100 
pJL272 (inv+) and MC4100 pRI203:: 
TnphoA (inv-) (inset).  p < 0.005.    
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Because expression of F1 is known to interfere with invasion, we speculated that 
the difference we observed may be due to repression of F1 production under high-
oxygen-availability conditions.  Samples of bacteria from each growth condition were run 
on a denaturing SDS-PAGE and probed with monoclonal F1-specific antibody, or with 
polyclonal Pla-specific antibody as a loading control.  As shown in Figure 11, F1 
expression was significantly decreased when bacteria were grown on solid media in the 
presence of oxygen compared to bacteria grown on solid media within the 
microaerophlllic chamber (compare lanes 5 and 6). 
 
 
 
 
 
 
 
 
 
An F1 deletion mutant of KIM6 retains invasive ability at 37°C 
 
If reduced F1 expression is responsible for the enhanced invasive activity of 
bacteria grown with high oxygen availability at 37°C, the invasive capacity of an F1-
deletion mutant should be independent of oxygen availability or temperature during 
growth.  We constructed an unmarked F1-deficient strain of Y. pestis by allelic exchange 
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Figure 11.  Detection of F1. 
Samples of bacteria from each 
growth condition as in Figure 8 
were separated on SDS-PAGE 
PAGE and then transferred to a 
PDVF membrane and probed with 
F1-specific monoclonal antibody 
(Meridian Life Sciences).  As a 
loading control, a duplicate 
membrane was probed with anti-Pla 
polyclonal antibody.     
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and tested its invasive ability compared to the parental strain, KIM6.  KIM6 and KIM6 
(Δcaf1) were grown under relevant temperature and oxygen regimes at 37°C, and 
samples of bacteria were assayed for invasive ability with WI26 cells.  As shown in 
Figure 12, neither oxygen availability nor temperature significantly affected the invasive 
ability of KIM6 (Δcaf1), but has significant effects on KIM6.   
 
Figure 12. An F1 deletion mutant retains invasive ability at 37°C independent of 
oxygen availability.   KIM6 F1+ (pgm- pCD1-) and KIM6 F1- (pgm- Δ caf1 pCD1-) were 
grown to log phase at 30°C or 37°C in liquid (L) or on solid media (S) under atmospheric 
oxygen levels (O2+) or in a microaerophillic chamber (MA). A standard gentamycin 
protection assay was conducted using WI26 cells as in Figure 8 with samples of Y. pestis 
grown under conditions described above. Assays were conducted in triplicate wells in at 
least three separate experiments. **p < 0.005 (invasion efficiency as compared to 37°C-
grown on solid media)..    
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In vivo Experiments   
 
These results led us to speculate that Y. pestis may have specific adaptations to 
growth in the upper airways where oxygen levels are high.  Experiments by Davis et al. 
demonstrate that infection of African Green monkeys with the fully virulent Y. pestis 
strain CO92 is not dependent on the presence of F1 [42].  However, these studies were 
conducted with bacteria grown in liquid culture at 30°C.  Thus, F1 was not present at the 
time of infection, and in vitro studies show that bacteria need multiple generations to 
make sufficient F1 (data not shown).  Conclusive data on the role of F1 during intranasal 
challenge is not available. 
 
To test the hypothesis that high-oxygen grown Y. pestis has enhanced ability to 
produce disease, perhaps via invasion/colonization of the nasopharynx, we conducted 
survival experiments comparing the virulence of bacteria grown under these two 
conditions.   For these experiments, we followed methods similar to those as described by 
Iyer et al. to establish nasopharyngeal colonization with Streptoccous pneumoniae [103].  
We infected mice with a small volume (4ul) of Y. pestis KIM1001 pBR322Δtet instilled 
in the nose.  We compared the survival of mice infected with bacteria grown at 
atmospheric levels of oxygen to bacteria grown under microaerophillic conditions.  
Surprisingly we found the difference in oxygen availability had the opposite effect than 
we hypothesized.  By day four, 4 of 5 of the mice infected with the highest dose (2 x 104 
CFU) of microaerobically grown Y. pestis had died, while 5 of 5 mice infected with 
bacteria grown under atmospheric levels of oxygen were still alive (Figure 13).  By day 
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12, all mice infected with the highest dose of microaerobically grown Y. pestis had died, 
while mice infected with bacteria grown under atmospheric levels of oxygen died more 
slowly, with 2 of 5 still alive at the conclusion of the study.  At a lower dose  (4 x 103 
CFU), 4 of 5 mice infected with microaerophillically grown bacteria died between days 
five and nine, while we observed no deaths when mice were infected with bacteria grown 
under atmospheric levels of oxygen. 
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Figure 13.  Y pestis grown under 
microaerophillic conditions are 
significantly more virulent than 
aerobically-grown bacteria in 
mice following low volume 
intranasal instillation. KIM1001 
pBR322 Δtet was  grown under 
atmospheric levels of oxygen (Δ) or 
in a microaerophillic chamber  (?) 
for 24 hours on solid TB agar at 
37°C. Bacteria were harvested from 
plates and resuspended in sterile 
water. Using a turbidity standard of 
0.35, bacteria were diluted to the 
appropriate concentration in 
endotoxin-free, injection grade PBS 
(Cambrex) and confirmed by 
plating on TB. Five animals per 
group of C57Bl/6 mice were 
anesthetized with ketamine/ 
xylazine and were infected by 
intranasal instillation with 4μl of 
the inocula.. Survival was 
monitored for 7 days. Dose: 2 x 104 
CFU (Panel A), 4 x 103 CFU (Panel 
B), 800 CFU (Panel C).  Mice in 
both groups given the lowest dose 
(160 CFU) survived.  The 
experiment was performed once at 
each dose.  Mice were monitored 
for survival for 12 days.  Survival 
curves were compared by log-rank 
test and p values were determined. 
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\Y. pestis bacteria do not survive inside cultured epithelial cells 
 
 To determine if bacteria are able to replicate after entering the intracellular 
environment of cultured WI26 cells, internalized bacteria were quantified by gentamycin 
protection assay over a 12-hour period after infection. We infected WI26 monolayers 
with D1 (pgm -) or KIM6 (pgm - pCD1-) grown at 30°C or 37°C on solid media and 
conducted a standard gentamycin protection assay.  As shown in Figure 14, once inside 
the cell, bacterial numbers steadily decline in number, until virtually no bacteria can be 
recovered from the interior of the cell.  This result, in combination with the infection 
experiments detailed above, argue against invasion occurring in vivo. 
 
 
 
 
 
 
 
 
 
Figure 14.  Intracellular survival following infection of WI26 cells.  WI26 cell 
monolayers were infected with D1 (pgm -), KIM6 (pgm - pCD1-) grown at 30°C or 37°C 
on solid media or with invasin-expressing or vector control MC4100 (inset).  Standard 
gentamycin protection assays were performed as in Figure 8.  After gentamycin 
treatment, cells were extensively washed with serum-free RPMI and allowed to incubate 
for 3 or 6 hours in the absence of gentamycin.  Intracellular bacteria was quantified as in 
Figure 8.     *p < 0.05    **p<0.005 
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Table 2.  Bacterial strains and plasmids 
 
Strain/Plasmid Properties Source or Origin 
Yersinia pestis  
  KIM1001 
  KIM1001pBR322Δtet 
  D1 
  KIM5 
  KIM6 
  JG153 
  JG154 
 
pgm+ ; pMT+, pCD1+ pPCP1+ 
pgm+ ; pMT+, pCD1+ pPCP1+ AR 
pgm- ; pMT+, pCD1+ pPCP1+ 
pgm- ; pMT+, pCD1+ pPCP1+ 
pgm- ; pMT+, pCD1- pPCP1+ 
pgm- ; pMT+, pCD1+ pPCP1- 
pgm- ; pMT+ , pCD1-; pPCP1- 
 
[6] 
[14] 
KIM derived, our laboratory 
KIM derived, our laboratory 
KIM derived, our laboratory 
KIM derived, our laboratory 
KIM derived, our laboratory 
Escherichia coli 
  MC4100pR!203::TnphoA 
  MC4100pJL272 
  β2155 
 
Inv-;  AR 
Inv+;  AR 
Provides RP4 conjugation functions, 
pi protein for pi dependent suicide 
vectors; DAP auxotroph; KR 
 
Gift of J. Leong 
Gift of J. Leong 
Gift of B. Akerley 
Plasmids 
  pRE107 
   
 
  pK101 
   
  pBR322 Δtet 
   
  pGK01ΔxylB       
 
pi dependent suicide vector; AmpR; 
sacB 
 
pRE107; caf1 amplicon insertion 
 
pBR322 (Invitrogen), TS 
 
pGK01; xylB amplicon insertion 
 
Gift of D. Schifferli 
 
 
This study 
 
[14] 
 
Gift of B. Akerley 
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Discussion 
 
Although fleas play an important role in the transmission of Yersinia pestis 
between mammalian hosts in nature, transmission can also occur by other routes.  In 
epidemics within human populations, airborne transmission, primarily via droplets rather 
than fine aerosols, is thought to be important.  Studies conducted during Manchurian 
pneumonic plague epidemics of the early 1900’s revealed that droplet transmission, not 
nuclei, were more likely to be responsible for bacterial spread via coughing.   During this 
epidemic, physicians treating plague-infected patients wore simple gauze masks that were 
sufficient to prevent transmission [94].  The poor efficiency of droplet penetration to the 
deep lung suggests the hypothesis that droplet transmission involves preliminary 
colonization of the upper airways and/or nasopharynx.  
 
A key finding of this work is that the ability of Y. pestis to invade cultured 
epithelial cells is enhanced by growth during direct exposure to air, and that this 
enhancement is due to the repression of F1 production.  This observation suggested to us 
that Y. pestis grown in air might have enhanced ability to colonize the nasopharynx. This 
ability could in turn result in enhanced vector-independent transmission, particularly if 
such colonization ultimately progresses to pneumonic infection.  
 
 One approach to testing this hypothesis is to establish a model of nasopharyngeal 
infection in mice and determine if the initial infection progresses to pneumonic disease 
and if growth conditions, particularly growth in air, affect the outcome of infection. In 
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and initial attempt to establish such a model, we adapted the low-volume intranasal 
instillation model of Iyer et al. used to establish nasopharyngeal colonization of 
Streptococcus pneumoniae to Yersinia pestis. [103].  Initial experiments with this model 
have yielded interesting, but unexpected, results.   
 
For bacteria grown with exposure to air, forty percent (2 of 5) of mice receiving 
an inoculum of 2x 104 CFU died as did 1 of 15 animals in lower dose groups.  These 
deaths occurred between 4.5 and 5 days post-infection.  Animals infected with bacteria 
grown under microaerophillic conditions behave differently in that none of the animals in 
the high dose group survived and 4 of 5 deaths occurred on day three.  Based on these 
results, it is unlikely that the difference in LD50 between the two growth conditions is 
greater than 10-fold. 
 
The rapid deaths of mice infected with microaerophillically grown bacteria is 
similar to that observed in models of primary pneumonic plague and suggests that 
pulmonary infection was established very early and progressed quickly.  Two possible 
explanations for this result are that a larger number of bacteria reach the lung 
immediately after inoculation or that these bacteria were more resistant to host defenses 
during the initial stages of infection than their air-grown counterparts.  At present, we 
cannot distinguish between these hypotheses, but the possibility that F1 expression 
induced microaerophillia results in more efficient penetration to the lung is an intriguing 
one.  Whatever the mechanism, these results demonstrate the influence of growth 
conditions on the outcome of infection experiments and indicate a need to establish what 
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conditions yield bacteria with greatest phenotypic virulence.  It is these conditions that 
should be employed in preparing inocula for use in protection studies for evaluating 
vaccine efficacy.   
 
We do not yet know the basis of this phenotypic difference in virulence.  It is 
likely to involve the increased expression of F1 under microaerophillic conditions.  This 
can be readily tested in parallel experiments with a specific F1 mutant.  If a preliminary 
colonization stage following low-volume intranasal instillation is established and goes on 
to produce pneumonic or systemic infection, we would expect this to be reflected by 
extended post-infection survival.  
 
While the delayed deaths observed in the high dose group infected with air-grown 
bacteria may be consistent with a requirement for upper airway colonization, increased 
susceptibility to anti-bacterial defenses or more limited penetration of the initial inoculum 
directly to the lung could also have this effect.  This, in the absence of any direct data on 
naso-pharyngeal colonization, prevents us from drawing conclusions regarding 
colonization at present.  
 
An additional series of experiments can readily address these issues.  The relative 
ability of bacteria grown under the two conditions to reach the lung rapidly following 
inoculation can be assessed by direct measurements of bacteria in the lung tissue excised 
from the bronchial tree a short time (e.g. 1 h) after infection.  Marked strains have been 
constructed to do these experiments with a mixed inoculum.  Because the phenotypic 
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difference established by growth prior to infection is likely to be transient in vivo, the 
relative abilities of both wildtype and F1- bacteria grown under different oxygen regimes 
to colonize the naso-pharynx can also be compared by direct measurements of bacteria in 
the naso-pharynx.  One interesting possible outcome of such experiment would be the 
finding that F1- bacteria colonize efficiently but are much less likely to cause pulmonary 
infection.  Another interesting question this raises is whether there are regions of the 
naso-pharynx that have a sufficiently oxygen rich atmosphere to repress expression of F1.  
This would probably be true in the immediate vicinity of the nares. 
 
Oxygen availability as an environmental cue for gene expression has not 
previously been demonstrated for Y. pestis.  Temperature, host-cell contact and pH have 
been the only recognized environmental cues for expression of many virulence factors.   
As F1 expression was never observed after growth at 30°C in liquid medium, our results 
indicate that 37°C growth is the primary cue and oxygen concentration serves as a 
secondary cue.  
 
In regards to the regulation of F1, we attempted to create a caf1R deficient strain. 
Using similar methods used to construct our F1-deficient Y. pestis KIM6, we were able to 
confirm the presence of the co-integrate form from over sixty individual isolates in at 
least three separate mating experiments.  Upon counter-selection on TB supplemented 
with 5% sucrose, all independent co-integrates resolved back to wildtype 100% of the 
time.   This result, as well as similar experiments by colleagues at UMMS, led us to 
speculate that the lack of caf1R may be a lethal mutation (Xiaoyu Hu UMMS, personal 
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communication).  Though a partial deletion mutant was described by Karlyshev et al., 
there is no mention in all the Yersiniae literature of a caf1R deficient Y. pestis [38].  
Further experiments will need to identify the sensor and how this signal is relayed either 
directly or indirectly to caf1R.   
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Chapter Five. 
Invasion of Cultured Epithelial Cells 
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Introduction 
 
Direct invasion of epithelial cells in vitro has been well-characterized by the 
enteric yersiniae.  The expression of the chromosomally-encoded invasin (inv) protein of 
Yersinia pseudotuberculosis in non-invasive Escherichia coli is sufficient for 
internalization into cultured mammalian cells [104-107].  Further investigation 
demonstrated that the specific binding of invasin to host β1 integrins mediated bacterial 
uptake [106].   However, in Yersinia pestis, invasin is not produced due to an insertion 
sequence within the inv gene [108].  The two other adhesins/invasins of the enteric 
yersiniae that have been identified, Ail and YadA, are also missing or inactive in Y. pestis.   
 
These genetic analyses, as well as experiments by Sikkema et al. and Rosqvist et 
al., indicated that, unlike the enteric Yersiniae, Y. pestis was unable to invade epithelial 
cells in culture [109]. Sikkema et al. observed that Y. pestis was completely unable to 
invade HeLa cells in vitro; however these studies were conducted in tissue culture media 
in the presence of 10% fetal bovine serum.  Rosqvist et al. also supplemented their media 
with 10% serum and used a Pla- strain of Y. pestis.  Subsequent studies would show the 
inhibitory effects of these conditions on invasion experiments with Y. pestis. 
 
More recently, multiple groups have reported the ability of Y. pestis to invade 
epithelial cells in vitro [41, 60].  Utilizing a gentamycin protection assay, Cowan et al. 
demonstrated that the presence of serum during the experiment significantly inhibited 
invasion of HeLa cells by Y. pestis.  Also, they reported that the presence of pPCP1 was 
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essential for high efficiency invasion (pPCP1+ vs pPCP1- at 26°C was equal to an 18-fold 
increase).  Their findings explain why data by previous groups led them to conclude Y. 
pestis to be non-invasive. In addition, their work defines some factors not required for 
invasion of HeLa cells by Y. pestis.  The absence of pCD1 or the pgm locus did not affect 
the ability to invade cells and this result was independent of growth temperature.  
However, growth of bacteria at 37°C significantly decreased invasion efficiency.  They 
speculated that Pla is the pPCP1-encoded factor that enhances invasion and the 
thermally-regulated F1 capsule peptide is responsible for the temperature-dependent 
inhibition that they observe.   
 
Pla is the only recognized virulence factor encoded on pPCP1; pst and pim encode 
pesticin, the yersinia bacteriocin, and its cognate immunity protein, respectively [2].  The 
ability of Pla alone to mediate internalization by non-invasive strains of E. coli has been 
reported by several groups.  Expression of Pla in the E. coli strains XL-1 or TB1 renders 
them invasive for the human endothelial cell line ECV304 or HeLa cells, respectively [29 
Benedek, 2004 #44].  This invasive ability is substantially less than of Y. pestis as 
reported by Cowan et al..  Unfortunately, these studies did not conduct a direct 
comparison of invasion between any Y. pestis strain and Pla-expressing E. coli.  
 
Benedek et al. attempted to ascertain the mechanism of Pla-mediated invasion.  
Not surprisingly, Pla-mediated invasion, but not adhesion, requires cytoskeletal 
arrangement within HeLa cells.   Preincubation of HeLa cells with nanomolar 
concentrations of staurosporin, genistein, or the actin inhibitor, cytochalasin D, blocked 
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invasion up to 50% [110].  This study attempted to address invasion from the perspective 
of the target cell, but did not address which functions of Pla are involved in invasion. 
Lahteenmaki et al. constructed point mutants of Pla that abolished proteolytic ability and 
expressed them in E. coli [29].  They observed no difference in invasion between 
wildtype and the protease defective mutant.  
 
Also using a gentamycin protection assay, a study by Liu et al. supported the 
hypothesis by Cowan et al. and demonstrated that F1 is the thermally regulated factor that 
inhibits invasion at 37°C [41].  They constructed a caf1 deletion mutant that restored 
invasion of A549 type II alveolar cells at 37°C.   
 
Interestingly, contrary to the results of Cowan et al. and our own observations, 
they report that the presence of pPCP1 had no effect on invasion.  We noted that in this 
study, bacteria were routinely grown in media different from our own to induce optimal 
expression of pH 6 antigen (brain heart infusion, BHI, versus TB).  Bacterial metabolism 
of glucose present in BHI (2 mg/ml) causes acidification of the media due to the 
accumulation of acetic acid products [111-113].  This difference in growth condition may 
not only effect the regulation of pH 6, but also may alter the regulation of proteins 
associated with invasion, namely F1 and Pla.  We asked whether this difference in growth 
condition had an effect on expression of either F1 or Pla.  We tested the expression of 
these two proteins after growth in media that supports expression of pH 6 antigen. 
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The purpose of this study was to better characterize Pla-mediated invasion of 
human lung-derived epithelial cells in culture by Yersinia pestis.  We addressed whether 
protease activity, adhesion, or plasminogen activation by Pla was involved in invasion. 
We demonstrate that expression of Pla from a vector utilizing the replication system from 
pPCP1 is unable to invade WI26 and HeLa cells when expressed in E. coli.    However, 
when a high copy number plasmid is utilized we observe modest ability to invade cells in 
culture compared to Y. pestis. 
 
Treatment of cells with a glycosylation inhibitor, previously shown to inhibit 
adhesion of Y. pestis (Thomas, 2006 #80}, resulted in a significant decrease in invasion.  
Interestingly, the difference observed was dependent on growth temperature of the 
bacteria.  Invasion of bacteria grown at 37°C were unaffected by the loss of glycosylated 
host cell surface proteins.  We were also able to exclude several integrins as potential 
receptors for the bacteria including the receptor for invasin, β1, and the predominant 
laminin-binding integrin, β4. Interestingly, even when we employed a F1- strain, Y. pestis 
grown at 37°C was not able to invade the cell line utilized in our 4 experiments.  
Collectively, these results led us to conclude that Y. pestis has at least two separate 
mechanisms capable of promoting invasion of cultured mammalian cells, and that 
utilization of these mechanisms is temperature dependent.  
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Materials and Methods 
 
Bacterial strains, plasmids and growth conditions.  The bacterial strains and plasmids 
used in this study are listed in Table 3. For liquid-grown Yersinia pestis, strains were 
grown in TB medium containing 10 g Bacto-tryptose, 5 g NaCl, 3 g Beef Extract (paste 
form, Difco Cat # 212610) per liter supplemented with 2.5 mM CaCl overnight at 30°C 
or 37°C as indicated.  For growth of solid-grown Yersinia pestis, 5 x 106 CFU were 
inoculated as a thin film and grown on TB medium supplemented with 2.5 mM CaCl and 
15 g per liter agar for 16 hours at 30°C or 37°C where indicated.  For growth of bacteria 
under a reduced oxygen environment, bacteria were inoculated onto TB agar as described 
above and incubated in an unvented polycarbonate jar (BBL) with a CampyPak™ Plus 
Microaerophillic System envelope (BBL).  pH6 antigen was induced by the addition of 2 
mg/ml glucose to the TB media.  Escherichia coli strains were grown at 37°C in Luria-
Bertani broth or on Luria-Bertani agar supplemented with 100μg/ml ampicillin.  MC4100 
pJL272 expressing invasin from Yersinia pseudotuberculosis and MC4100 pRI203 
Tn::phoA  (kind gift of John Leong, University of Massachusetts) were grown in LB 
media supplemented with 100μg/ml ampicillin.  To buffer TB media supplemented with 
glucose, 1 x M9 salts (43 mM NaCl, 93 mM NH4Cl, 110 mM KH2PO4, 450 mM 
Na2HPO4) were added.   
 
Cell Lines and Reagents.  The type I human alveolar epithelial cell line, WI26 
(American Type Tissue Collection, MD) and HeLa human epithelioid cells were 
maintained as described above.  MDA-435pcDNA3 vector control cells and MDA-435 
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pRc/CMV cells expressing the β4 subunit (generous gift of Leslie Shaw, University of 
Massachusetts Medical School, [114, 115] were maintained in Dulbecco’s modified 
Eagle’s Medium supplemented with 10% heat-inactivated fetal bovine serum and 
10μg/ml penicillin/streptomycin supplemented with 500 μg/ml G418 (Clontech).  F9 
cells (DKO, as there are three copies of β1 in this cell line) and their β1-deficient 
counterpart (TKO) were maintained in Dulbecco’s modified Eagle’s Medium 
supplemented with 10% heat-inactivated fetal bovine serum and 10μg/ml 
penicillin/streptomycin in flasks pre-treated with 0.1% gelatin for 2 hours at 4°C or in 24-
well tissue culture plates also treated with 0.1% gelatin for 2 hours 4°C for invasion 
assays {kind gift of John Leong, University of Massachusetts Medical School; {Stephens, 
1993 #218}.  All cell lines were maintained at 37°C with 5% CO2.  For glycosylation 
inhibition studies, cells were treated with 0.55μg/mL tunicamycin for 96 hours prior to 
infection (Sigma).  For blocking experiments, cells were pretreated with 5-20 μg/ml 
polyclonal anti-human laminin or anti-human fibronectin antibodies for one hour prior to 
infection (MP Biomedicals).  To determine the effect of plasminogen activation on 
invasion, bacterial cells were pretreated with 160nM human Glu- plasminogen at the 
indicated concentrations for one hour at 37°C prior to infection (Sigma). 
 
Cell Invasion.  Cells were seeded at 5 x 104 per well in 24-well tissue culture dishes 
(Costar) and grown overnight at 37°C with 5% CO2.  The day of the experiment, cells 
were washed twice with warm, serum-free RPMI 1640 (Invitrogen).  Bacterial cells were 
pelleted and washed once with phosphate-buffered saline (PBS, 135 mM NaCl, 2.68 mM 
KCl, 10 mM NaHPO4, 1.76 mM KH2PO4).  Bacteria were diluted into warm serum-free 
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RPMI 1640 at a concentration of 106 CFU/ml.  Warm medium was removed from the 
cells and one milliliter of the bacterial suspension was added to give a multiplicity of 
infection (MOI) of 10.   Tissue culture dishes were then centrifuged for 10 minutes at 182 
x g at room temperature and incubated for one hour at 37°C with 5% CO2.  Cells were 
washed as above and extracellular bacteria were killed by the addition of 50 μg/mL 
gentamycin in serum-free RPMI 1640 for one hour at 37°C with 5% CO2.  Cells were 
washed with RPMI and one ml of ice cold water was added to each well to lyse cells.  
Dishes were placed on ice for 10 minutes and intracellular bacteria were determined by 
serial dilutions of the lysate.  All experiments were done in triplicate wells in at least 
three independent experiments.  The final inoculum was verified by CFU determination.     
 
Cytotoxicity assay.  The Cytotoxicity Detection Kit (Roche) was used in accordance 
with the manufacturer’s instructions.  This kit measures release of lactate dehydrogenase. 
 
SDS-PAGE and Immunolotting. .   Total protein extracts from 5 x 106 Y. pestis cells 
were run on SDS-PAGE (10% acrylamide) (Biorad) at 100V for 1 hour. For 
immunoblotting, proteins were transferred to a PVDF membrane (Millipore) for 1 hour at 
100V. Membranes were blocked overnight in 5% nonfat milk in PBS (PBSM) at 4°C.  
Membranes were incubated with primary antibody diluted in 5% PBSM at room 
temperature with agitation for two hours.  After three washes for 5 minutes each in 
PBS/0.1% Tween, membranes were incubated with secondary antibody diluted in 5% 
PBSM at room temperature with agitation for two hours. After three washes for 5 
minutes each in PBS/0.1% Tween, membranes were washed for 20 minutes with high pH 
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Tris buffer (100 mM Tris Buffer, 100 mM NaCl, 5 mM MgCl2 pH 9.5) and developed 
with 0.005% 5-Bromo-4-Chloro-3-indolyl phosphate (BCIP)  (Sigma) and 0.005% nitro 
blue tetrazolium resuspended in high pH Tris Buffer. 
 
Antibodies.   Mouse anti-F1 monoclonal antibodies (clone VA18) were purchased from 
Meridian Life Sciences (formerly Biodesign). Polyclonal anti-Pla antibodies were 
produced in rabbits injected with E. coli over-expressing Pla and purified by ammonium 
sulfate precipitation followed by adsorption to pPCP1-deficient Y. pestis strain, JG153.  
Poly-clonal anti-pH6 antisera was a generous gift of Dieter Schifferli (University of 
Pennsylvania).  To remove non-specific antibodies, pH6 antiserum was adsorbed using 
whole cells of DSY23 resuspended in PBS and incubated for an hour at 4°C.  Alkaline 
phosphatase conjugated anti-mouse and anti-rabbit IgG were purchased from Sigma. 
 
Plasminogen activation assay.  To test determine plasminogen activation activity, 
reactions were performed with whole bacterial cells washed and resuspended in assay 
buffer (0.1 M Tris, 0.1% Tween pH 7.4).  Reactions were carried out in flat bottom 96-
well plates (Costar) with c.a. 107 cells, 180 nM human Glu-plasminogen (Sigma), and 
5nM of the chromogenic substrate Val-Leu-Lys-p-nitroanilide (Sigma, S2251) in 50μL 
final volume of assay buffer.   Substrate hydrolysis by plasmin was followed by 
recording the absorbance at 405 nm over 60 minutes, and the rate of plasminogen 
activation calculated as the second derivative of the curve obtained.   
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Whole cell ELISA.  Bacterial cells from growth conditions described above were 
washed in 1 ml PBS and diluted in 0.1 M  NaH2PO4 / 0.1M Na2HPO4 buffer to 5 x 106   
CFU/ml.  Assay plates (ICN) were coated with 50μl/well of the bacterial suspension and 
allowed to incubate overnight at 4°C.  Plates were blocked with 1% BSA diluted in PBS 
for one hour at room temperature.  F1-specific antibodies were diluted in 1% BSA/PBS.  
Fifty microliters was added to each well of the assay plate and incubated for two hours at 
room temperature.  Plates were washed three times with PBS and 0.1% Tween.  Anti-
mouse IgG was added at a concentration of 1:10,00 in 1% BSA/PBS and incubated for 
two hours at room temperature. Plates were washed three times with PBS/0.1% Tween.  
Plates were developed with p-nitrophenyl phosphate (Sigma) and absorbance read at an 
optical density (OD) of  405 nm. 
 
Results  
 
Part I:  Pla-mediated invasion  
 
 Pla expressed in E. coli 
 Our observations, as well as observations by Cowan et al., indicate that 
expression of Pla significantly enhances invasion of cultured epithelial cells by Y. pestis.  
It has not been demonstrated which function(s) of Pla are involved in invasion, or if Pla 
acts alone or in conjunction with another factor. A study by Lahteenmaki et al. shows no 
requirement for the protease activity of Pla for the invasion of endothelial cells in culture 
[29].   Using E. coli strains that express Pla or Pla point mutants that disrupt protease 
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activity, they demonstrate that Pla point mutants without protease activity had no defect 
in invasion as compared to wildtype, though no comparison of invasion by any Yersinia 
pestis strain was conducted for comparison.  
 
We transformed the E. coli strain XL-1 with the Pla-expressing plasmid, pPLAI, 
or the vector control, pOS50. As shown in Table 3, this vector is a pBR322 derivative but 
contains the origin of replication from pPCP1 resulting in a plasmid with a similar copy 
number to that of pPCP1. We confirmed the expression of Pla in XL-1 by Western blot 
and its protease activity as measured by plasminogen activation assay as 
indistinguishable from that of wildtype Y. pestis (data not shown). We tested each strain 
for its ability to invade WI26 and HeLa cells as quantified by gentamycin protection 
assay.   As shown by Figure 15A, XL-1 expressing Pla was completely unable to invade 
either HeLa or WI26 cells.   
 
These results are different from those obtained by Benedek et al. and 
Lahteenmaki et al., where expression of Pla in E. coli was sufficient for invasion of 
cultured epithelial cells.   However, the constructs used in these studies utilized plasmid 
vectors from the pUC family, and thus have a much higher copy number than the pOS50 
constructs used in the experiments described above. 
 
To investigate this effect of this difference, Pla was cloned in a pBluescript vector 
(pBSpla), also pUC-derived, and was transformed into XL-1. The ability of XL-I 
expressing Pla to invade HeLa and WI26 cells was assessed by gentamycin protection 
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assay.   As shown by Figure 15B, these strains are able to invade cultured cells, but to a 
much lesser extent that Y. pestis.  Given these results, we hypothesize that in the context 
of Y. pestis, Pla does not mediate invasion alone, but rather in conjunction with other 
factors. 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
  
Figure 15.  Pla-mediated invasion by E. coli. The E. coli strain, XL-1, was transformed 
with a vector control (pOS50) or pPLA1.  XLI pPLA1 constitutively expresses a 
proteolytically active Pla (A). WI26 cells were seeded 5 x 104 cells per well in a 24-well 
tissue culture dish.  Bacteria were washed once with PBS and resuspended in serum free 
RPMI at an MOI = 10.  Cell monolayers were infected for an hour with the indicated 
strains.  Intracellular bacteria were quantified by gentamycin protection assay (A).  Same 
as in A, but XLI was transformed with the vector control, pBS, or with pBSPLA, which 
overexpresses Pla. 
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  Protease Activity  
 We asked if the protease activity of Pla was required for invasion of cultured 
epithelial cells.  We tested two point mutants of Pla for their ability to invade both HeLa 
and WI26 cells.  As shown in Figure 16, the requirement for protease activity of Pla 
expressed in Y. pestis is dependent upon the cell line tested.  For the human type II 
alveolar epithelial cell line, WI26, protease activity is required.  However, protease 
activity of Pla is not required for the invasion of HeLa cells.  This result is consistent with 
results obtained from other groups (S. Straley, personal communication). 
 
 
 
 
 
 
 
 
 
 
Figure 16.  The role of protease activity of Pla in invasion of cultured epithelial cells. 
HeLa and WI26 cells were seeded 5 x 104 cells per well in 24-well tissue culture plates 
and allowed to incubate overnight.   Monolayers were infected for one hour with bacteria 
grown in liquid media at 30°C.  Intracellular bacteria was quantified by gentamycin assay 
as described above in Figure 8.. *p < 0.05 as compared to JG154 pPLAI. 
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 Extracellular Matrix Binding 
 Binding extracellular matrix components and/or integrins is a common 
mechanism used by bacteria in the invasion of cultured mammalian cells.  Enteric 
Yersiniae utilize β1 integrins to mediate internalization, and it has been shown that 
Staphylococcus aureus and Streptococcus pyogenes use extracellular matrix components 
to mediate internalization.  The fibronectin-binding protein (FnBP) of S. aureus binds to 
fibronectin which acts as a bridge to α5β1 integrins to mediate uptake [116]. Similarly, 
the surface-expressed Sfbl protein of S. pyogenes also binds fibronectin and is 
internalized via interaction with α5β1 [117].  
 
The ability to bind of Pla to bind laminin prompted us to determine if Y. pestis 
utilizes a similar mechanism for internalization. We asked if binding of laminin or a 
laminin-specific receptor was involved in invasion by Pla-expressing strains of Y. pestis. 
To address this question, we used two approaches.  First, we attempted to block the Pla-
laminin interaction using anti-laminin specific antibodies. Cell monolayers were 
incubated with either anti-laminin or anti-fibronectin antibodies or with RPMI alone.  
Reports by Sinha et al. indicate that incubation of 20 μg/ml anti-fibronectin antibodies 
with cultured epithelial cells was able to inhibit invasion by S. aureus [116].  Cells were 
infected with KIM6, JG154, or MC4100 (pJL272) expressing invasin or with the vector 
control.  Intracellular bacteria were quantified by gentamycin protection assay.  No 
difference in invasion efficiency of any strain was ever observed in the presence of anti-
laminin antibodies. 
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Second, we tested whether the cell line MDA-435 transiently transfected with the 
integrin subunit, β4, were able to internalize Pla-expressing bacteria better compared to 
vector-transfected cells.  Unlike HeLa and WI26 cells, which are epithelial cell derived, 
MDA-435 cells are derived from breast cell carcinoma. MDA-435 cell monolayers 
transfected with the β4 subunit or the pcDNA3 vector control expressing α6β1 were 
infected for one hour and intracellular bacteria was quantified by gentamycin protection.  
We observed that after infection with 30°C-grown Y. pestis, invasion is not significantly 
influenced by the presence of the β4 subunit. (Figure 17, Panel A).  We speculate that if 
Y. pestis utilizes α6β4 to mediate bacterial entry, its contribution may be relatively small.   
 
Interestingly, in all our invasion experiments with MDA-435 cells, infection of 
cells with 37°C-grown Y. pestis resulted in no observable invasion, with or without the 
presence of β4.  Invasion was never observed in any Y. pestis strains tested, including an 
F1- strain (Figure 17 Panel B).  This data, along with experiments outlined below lead us 
to hypothesize that their are least two mechanisms for invasion and that expression of at 
least one of these is strongly dependent on growth temperature. 
  
Though invasion of cell line, MDA-435, was never observed by 37°C-grown Y. 
pestis, we asked if cell adhesion and/or cytotoxic effects of the type three secretion 
apparatus would also be non-functional.  To date, there has not been a cell line identified 
that is not susceptible to the effects of TTSS.  Infection of both WI26 and MDA-435 cells 
by KIM6 F1- grown at 30°C and 37°C resulted in significant adhesion (data not shown).  
In addition, MDA-435 was similarly effected by the cytotoxic effects of the type three 
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secretion system by 37°C-grown Y. pestis.  Bacteria pre-grown to early log phase at 30°C 
were induced at 37°C for three hours.  TTSS-sufficient and deficient bacteria were 
inoculated onto cell monolayers for 18 hours. We found that strains sufficient in TTSS 
were cytotoxic to both HeLa and MDA-435 cells after 4 hours of incubation at 37°C. 
These data demonstrate that the mechanism for adhesion is not sufficient for invasion. 
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Figure 17. Invasion of 30°C-
grown Y. pestis is not influenced 
by the presence of the β4 
subunit of the laminin receptor. 
(A) MDA-435 cells were stably 
transfected with vector control 
(α6β1) or pRc/CMV expressing 
the β4 integrin subunit (α6β1/β4). 
Cells were seeded in 24-well 
tissue culture plates. The next day 
monolayers were infected for one 
hour with Y. pestis KIM6 F1- 
grown at 30°C (MOI = 10).  
MC411pJL272 (inv+) is included 
as a control.  Intracellular bacteria 
were quantified by standard 
gentamycin protection assay as in 
Figure 8. (B) WI26 cells and 
MDA-435 cells were seeded in 
24-well tissue culture plates. The 
next day, monolayers were 
infected for one hour with either 
30°C- or 37°C-solid grown Y. 
pestis KIM6 F1-. (MOI = 10). 
Intracellular bacteria were 
quantified by standard 
gentamycin protection assay as in 
Figure 8.  ***p < 001, 30°C-grown 
v.s. 37°C-grown KIM6 F1- 
 
30°C            37°C 
*** 
p = 0.4 
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 Plasminogen Activation 
 One of the main functions of Pla is its ability to activate plasminogen.  Activation 
of plasminogen by Pla has also been observed to degrade laminin [28].  We asked if 
plasminogen activation of Pla would enhance invasion of cultured epithelial cells.  Cell 
monolayers were either pre-treated with human plasminogen for one hour prior to 
infection by Y. pestis or cells were treated at the time of bacterial inoculation.   
Intracellular bacteria were quantified by gentamycin protection assay. Pre-incubation of 
cells with plasminogen or concurrent plasminogen treatment and infection did not result 
in any decrease in invasion efficiency by pPCP1+ Y. pestis (incubation with 1μM Glu- 
plasminogen resulted in less than a 1.35-fold difference in invasion).  The presence of 
plasmin and possible degradation of laminin had no effect on invasion efficiency by Y. 
pestis.  Nor did the binding of Pla to plasminogen have any inhibitory effect on invasion. 
 
 Pla expression is repressed by pH 
 Results by Liu et al. indicate that the presence of pPCP1 had no effect on 
invasion.  Studies by Cowan et al. and our own work have shown that pPCP1 and Pla, 
respectively, enhance invasion five to eighteen fold (Cowan et al, see figure 17 of this 
work).  We asked if growth conditions utilized by Liu et al. that induced expression of pH 
6 antigen had an effect on proteins we know to be important in invasion in vitro.  As a 
standard practice for optimal induction of pH 6 antigen, bacteria were grown in TB 
supplemented with 2mg/ml glucose, the concentration found in BHI, the medium used by 
Liu et al.  KIM6 was grown overnight as a thin film on TB agar supplemented with 
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2.5mM CaCl with or without 2mg/mL glucose at 30°C or 37°C under atmospheric levels 
of oxygen or within the microaerophillic chamber. Western blotting of  whole cell lysates 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Bacteria were grown in liquid culture at 30°C in shaking culture flasks in the presence or 
absence of glucose (2 or 0.7mg/ml) or xylose (2mg/ml) where indicated.  Samples of 
bacteria were taken at different intervals and Pla expression was assessed as in panel A. 
Number s below indicate hours of incubation.  For example, at 3 hours, the pH of TB 
alone was 7.12, while that of TB + 2 or 0.7 mg/ml glucose was 6.58.  The pH of cultures 
containing xylose was 7.06 (B). at different intervals and Pla expression was assessed as 
in panel A. Number s below indicate hours of incubation.  For example, at 3 hours, the 
pH of TB alone was 7.12, while that of TB + 2 or 0.7 mg/ml glucose was 6.58.  The pH 
of cultures containing xylose was 7.06 (B). 
 
demonstrated minimal differences in pH6 antigen expression in response to oxygen 
availability but more interestingly, a significant difference in the expression of Pla was 
detected when bacteria were grown on media containing glucose (Figure 18 A).  
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Figure 18.  Pla expression is 
repressed by pH. (A) 
Bacteria were grown to log 
phase at 30°C or 37°C in 
liquid or on solid media 
grown under atmospheric 
levels of oxygen (air) or in a 
microaerophillic chamber 
(MA) in the presence or 
absence of 2 mg/ml glucose.  
Whole cell lysates from each 
condition were run on 
duplicate 10% SDS-PAGE, 
transferred to a PVDF 
membrane and then probed 
for the presence of Pla with 
polyclonal Pla-specific anti-
body and the presence of pH6 
antigen with ployclonal anti-
pH 6 antibody.  Note that 
under any growth condition 
containing glucose, Pla 
expression is significantly 
reduced, compared to pH6 
expression, which is induced 
under low (c.a. 6.2-6.4) pH. 
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Furthermore, this result was independent of growth temperature and oxygen availability, 
as Pla was repressed at both 30°C and 37°C in the presence of glucose.   Growth of 
bacteria in TB supplemented with M9 buffer did not yield any repression of Pla (data not 
shown), confirming that the change in pH was responsible for the difference in Pla 
expression observed. 
  
 To address this finding further, we conducted an experiment to observe when 
during growth and at what pH Pla was being repressed.   A significant decrease in Pla 
was noted early in growth at a moderately lower pH (6.5) (Figure 18 B).  These data 
indicate that Pla and pH 6 antigen are not actively expressed together.  They also may 
explain the conclusions of invasion experiments of Liu et al..  They state that the 
presence of pPCP1 had no effect on invasion, though the intent of their study was to 
show the role of pH6 antigen in invasion, which is illustrated in their growth condition; 
brain heart infusion media supplemented with glucose. 
 
 We asked if F1 was similarly affected by pH conditions of the growth media. We 
similarly tested the effect of lower pH on the expression of F1.  Surprisingly, we were 
able to demonstrate by whole cell ELISA and by western blot that bacteria grown in TB 
supplemented with 2 mg/ml glucose decreased F1 expression (Figure 19).   
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Part II: Adherence and Invasion 
 
 Tunicamycin treatment inhibits the biosynthesis of high-mannose and complex 
glycoproteins in mammalian cells.  Reducing the surface expression of oligosaccharides 
by tunicamycin treatment significantly decreased the ability of Streptococcus 
pneumoniae and Legionella pneumophila to adhere to the alveolar epithelial cell line, 
A549 [118].  Studies by Thomas et al. tested the hypothesis that adhesion of the fully 
virulent Y. pestis strain, GB, would similarly be decreased in response to a reduction in 
host cell glycoproteins.  They demonstrate adhesion was decreased 55-65% after 
tunicamycin treatment of alveolar epithelial cell line, A549, and the bronchial epithelial 
cell line, BEAS2-B [119]. 
 
These observations by Thomas et al. indicate that Y. pestis uses an 
oligosaccharide moiety on the surface of mammalian cells for.  Adhesion is likely an 
                           air                               MA         O2 
             -  +      -        +    glu 
Figure 19. F1 is repressed 
by low pH.  KIM5 was 
grown at 37°C on solid TB 
agar with or without 2mg/ml 
glucose under atmospheric 
(air) or microaerophillic 
conditions (MA).  Whole 
cells from each condition 
were assayed for the 
expression of F1 with 
monoclonal anti-F1 anti-
body by whole cell ELISA 
(as described in the Material 
and Methods). 
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important step in invasion by Y. pestis, though it is unclear what receptor Y. pestis binds 
to mediate internalization.  We tested whether decreased glycosylation on the cell surface 
of would effect invasion of WI26 cells. Monolayers were cultured in the presence of 
0.55μg/mL tunicamycin for 96 hours.  At this concentration, tunicamycin was not 
cytotoxic to WI26 cells as demonstrated by a cell cytotoxicity assay (data not shown).  
After an hour infection, intracellular bacteria were quantified by gentamycin protection 
assay. 
 
As shown in Figure 20, tunicamycin treatment decreased invasion by 30°C-grown 
Y. pestis by approximately 70%, indicating that adhesion to oligosaccharides mediates 
invasion.  Tunicamycin treatment of WI26 cells had no effect on invasion by MC4100 
pJL272.  Observations that tunicamycin treatment decreased invasion by 30°C-grown, 
but not 37°C-grown Y. pestis led us to speculate that Y. pestis utilizes two separate 
mechanisms for invasion that are dependent on growth temperature.  Protein(s) expressed 
at 30°C that are required for invasion are likely to bind these glycosylated molecules, 
whereas protein(s) expressed at 37°C do not require glycosylated surface expressed 
molecules.   Also, this result indicates that the 30°C mechanism is not operative at 37°C. 
This result led us to speculate that adherence and invasion may be independent functions. 
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Figure 20. Tunicamycin treatment of WI26 cells specifically inhibits invasion by 
30°C-grown, but not 37°C-grown Y. pestis. WI26 cells were seeded in 24 well tissue 
culture plates and were treated for 96 hours with 0.55 μg/ml tunicamycin diluted in tissue 
culture media. .  F1-deficent Y. pestis was grown overnight in liquid medium at 30°C or 
37°C.  Cells were infected for an hour with bacteria at an MOI = 10.  Intracellular 
bacteria were quantified by gentamycin protection assay as in Figure 8. **p < 0.005, 
treated v.s. untreated. 
 
 
Part III.  Y. pestis utilizes a separate invasion pathway from Y. pseudotuberculosis 
 
 In an attempt to determine the mechanism of Y. pestis-mediated invasion from the 
host cell perspective, we asked whether bacterial binding of β1 integrins, similar to 
invasin of Y. pseudotuberculosis, was involved in internalization. Binding of integrins, 
either directly or indirectly is a common mechanism of invasion by both Gram-positive 
and Gram-negative bacteria. Utilizing a standard gentamycin protection assay, F9 cells 
containing one intact copy of the β1 gene (DKO) and its β1- deficient counterpart (TKO) 
were infected with MC4100inv-, MC4100pJL272 or Y. pestis KIM6.  As shown in Figure 
21, the lack of β1 integrins had no effect on invasion by Y. pestis, but no invasion by 
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invasin-expressing E. coli was observed in the absence of β1 integrins.  We conclude 
from these experiments that Y. pestis utilizes a separate mechanism from Y. 
pseudotuberculosis to mediate internalization. 
 
 
 
 
 
 
 
 
 
 
Figure 21.  Y. pestis utilizes a separate invasion pathway from Y.  pseudotuberculosis.  
β1-sufficient F9 cells (DKO) and β1-deficient cells (TKO) were seeded 5 x 104 in a 24-
well tissue culture dish pretreated for 24 hours with 0.1% gelatin.  Cell monolayers were 
infected with the indicated strains for one hour.  Intracellular bacteria were quantified by 
gentamycin protection assay as in Figure 8.   MC4100pJL272 and MC4100pR1203 are 
shown as controls for invasion efficiency (inset). 
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Table 3.  Bacterial Strains and Plasmids 
 
 
Strain/Plasmid Properties Source or Origin 
Yersinia pestis  
  KIM6 
  KIM6 F1- 
  ]JG154 
 
pgm- ; pMT+, pCD1- pPCP1+ 
pgm- ; pMT+ Δcaf1 , pCD1- pPCP1+  
pgm- ; pMT+ , pCD1-; pPCP1- 
 
KIM derived, this laboratory 
This study 
KIM derived, this laboratory 
Escherichia coli 
  MC4100 pR!203 
  MC4100 pJL272 
  XL1 
 
Inv-;  AR 
Inv+;  AR 
 
 
Gift of J. Leong 
Gift of J. Leong 
Stratagene             
Plasmids 
  pOS50 
 
  pPLA1 
 
 
  pPLAD104E 
 
  
 pPLAD104E 
 
  pBS 
 
  pBSPla 
 
pBR322 derived, pPCP1 ori 
 
pOS50; Pla +; protease activity + ;3.2 kb 
HindII frag of pPCP1; 
 
pOS50; Pla +; protease activity - ;3.2 kb 
HindII frag of pPCP1; 
 
pOS50; Pla +; protease activity - ;3.2 kb 
HindII frag of pPCP1; 
 
 
Pla +; protease activity + 
 
[26] 
 
[26] 
 
 
our laboratory 
 
 
our laboratory 
 
Stratagene 
 
our laboratory 
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Discussion 
 
This work demonstrates that unlike invasin of the enteric yersiniae, we have yet to 
identify a single protein in Yersinia pestis that can mediate efficient invasion of cultured 
epithelial cells.  Though the presence of the Pla protease enhances invasion in Y. pestis as 
was first observed by Cowan et al.. In E. coli overexpression of Pla is required to 
promote even moderate levels of invasion.  In contrast, invasion by Y. pestis seems to be 
a complex process involving multiple factors, some of which have temperature dependent 
expression.  Moreover, the requirements for invasion differ significantly among cell lines.  
For example, the protease activity of Pla is required for invasion of WI26 cells but not for 
HeLa cells.   At present, we have no clear indication of the receptor(s) or cell surface 
proteolytic targets are involved.  
 
Our evidence indicates at least two separate pathways for invasion by Y. pestis 
that depend on growth temperature of the bacteria.  For example, 30°C-grown Y. pestis 
will invade MDA-435 cells, but 37°C-grown will not.  Nonetheless 37°C grown bacteria 
readily invade WI26, HeLa, and F9 cells.  Results from tunicamycin treatment 
experiments also indicate multiple pathways.   The invasion of WI26 cells by 30°C 
grown bacteria is reduced by tunicamycin, while invasion by 37°C grown bacteria is 
unaffected. This suggests the involvement of glycoproteins in invasion of 30°C grown 
bacteria, but not 37°C grown bacteria.  Differences between invasion observed at 
different temperatures is highly unlikely to be related to Pla expression because Pla is 
expressed equivalently at both temperature regimes used.  These pathways that are 
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differentiated by the temperature response almost certainly involve bacterial factors other 
than Pla.  
 
The failure of 37°C grown bacteria to invade MDA-435 cells strongly suggests a 
missing a factor that is present in the other cell lines tested.  It may be possible to exploit 
this difference to identify one important sole component contributing to invasion.  
 
Induction of pH 6 antigen under different oxygen concentrations was 
accomplished by supplementing growth media with glucose and incubation of bacteria at 
37°C.  Acidic products are produced during the metabolism of glucose, causing a drop in 
pH and expression of pH6 antigen.  Under these growth conditions, we observed 
significant differences in both Pla and F1 expression. Initially, we hypothesized that the 
added glucose may responsible for the differential expression levels of Pla and F1.  To 
answer this question we grew bacteria in TB media in the presence or absence of buffer.  
We conclusively demonstrated that pH, not glucose, was responsible for the repression of 
Pla and F1 that we observe.  Our results indicate that inducing conditions for pH 6 
expression represses expression of Pla and F1.  
 
These results have implications for many in vitro and in vivo experiments.   
Invasion studies by Liu et al. indicate, contrary to results by Cowan et al., that Pla has no 
effect on invasion.  We speculate, in light of these new regulatory cues, that conditions 
conducive to the expression of pH 6 antigen repressed Pla expression. The take home 
message from these studies is to be aware of growth conditions. 
 104
 
Given the evidence we have for multiple invasion pathways and subtle differences 
between invasion in different cell lines (e.g. Pla protease activity required in WI26 but 
not HeLa) and the current lack of any definitive evidence indicating that invasion is 
important during Y. pestis infection, it is important to question the relevance of invasion 
observed in vitro to pathogen biology.  It is perhaps likely that interactions between 
bacteria and cells in vitro that are essentially artifactual, in the sense that they do not 
represent significant interactions in vivo, more readily cause invasion phenomena than is 
generally thought.   If this view is correct, it may be injudicious to devote effort to the 
study of invasion when the only data to support the phenomena in question was obtained 
in vitro.   
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Discussion 
This work presents two major findings; first, we conclusively show that the 
LcrV/TLR2 interaction that has gained wide acceptance in the Yersiniae field, plays no 
role during infection with fully virulent strains of plague and second, we discovered 
novel environmental cues for the expression of several virulence determinants, most 
importantly, F1. 
 
 Until recently, the  hypothesis that interaction between Yersiniae LcrV and host 
TLR2 has an anti-inflammatory effect important in infection has been a widely accepted.  
With no clear data indicating that Y. pestis LcrV had similar activities or had any effect 
on the course of disease, Overheim et al. initiated work on the construction of a non-
TLR2 stimulating Y. pestis LcrV construct for use in vaccine development. We tested the 
stimulatory activity of recombinant LcrV from Yersinia pestis and found that the majority 
of protein had no TLR2 stimulating activity in vitro, and such activity was restricted to 
high molecular weight aggregates/multimers that contain LcrV but are of undetermined 
composition.   
 
Though we demonstrated an interaction between high molecular weight 
aggregates of Yersinia pestis rLcrV and host cell TLR2, this interaction had no significant 
consequence in vivo.  In a sensitive mouse infection model, elimination of TLR2 had no 
effect on the course of disease, bacterial load, or on cytokine levels.  Given the well-
established sensitivity of the Y. pestis mouse infection model, its lack of response to 
TLR2 deficiency must be regarded as strong evidence that TLR2-induced 
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immunomodulation does not have a significant role in plague.  This work, along with 
studies by Auerbuch and Isberg (2007) are show that this interaction is specific for some 
strains of Y. enterocolitica and certain strains of mice, but is not biologically relevant for 
Yersinia pestis.  Since the publication of this work, Sing et al. have reported additional 
studies in agreement with our conclusions.   
 
Vector-borne bacterial pathogens like Yersinia pestis that cycle between a vector 
and mammalian host encounter different environments and require strategies to control 
protein expression in a host-specific manner.  This can be accomplished via species-
specific environmental cues.  Signals such as temperature, pH, iron, oxygen tension and 
osmolarity control the coordinate expression of virulence determinants in many bacteria 
[120].  For Yersinia pestis, induction of genes involved in growth and transmission by the 
flea an in  rapid dissemination through evasion of innate immunity within the mammalian 
host need to be expressed in the appropriate environment.  For example, expression of the 
type three secretion system (TTSS) and its many effectors within the flea is not 
beneficial, nor energy efficient, for the bacteria. 
 
We previously demonstrated that increased oxygen availability significantly decreased 
expression of F1, which resulted in a greater ability to invade cultured epithelial cells.  
These novel observations of F1 regulation by oxygen availability led us to hypothesize 
that Y. pestis may utilize effective oxygen concentration to modulate other virulence 
genes.  Regulation of virulence factors by oxygen availability has been observed in 
several species of bacteria. For example, in Y. enterocolitica, Schiel et al. demonstrate 
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that yplA, which encodes a phospholipase A, is repressed under increased aeration 
conditions [121].  In group B Streptococci (GBS) shows enhanced invasion of multiple 
cell lines under high aeration conditions, although the mechanism underlying this 
phenomenon has not been identified [122, 123]. Probably the best-characterized 
regulation system controlled by oxygen tension is in found in Salmonellaspecies. 
Salmonella infects and penetrates intestinal epithelia, a microenvironment in which 
availability of oxygen is limited.  High oxygen tension decreases invasion efficiency of 
non-typhoidal Salmonella by repression of hilA, a transcriptional regulator of genes 
encoded within the Salmonella Pathogenicity Island 1 (SPI-1).  This is accomplished 
through the signal molecule guanosine tetraphosphate (ppGpp) whose regulation is 
required for both invasion and intracellular survival in the host [124]. 
 
Invasion of cultured epithelial cells has also been observed by many species of 
bacteria.  The mechanism of invasion for the enteric yersiniae has been well 
characterized from both the perspective of the bacterial and host cell.  Y. pestis is also 
invasive for cultured epithelial cells, though the mechanism is unknown.  Studies showed 
that this invasive ability was significantly reduced when bacteria were grown at 37°C, 
independent of the presence of pCD1.  This result led to disinterest in this process 
becuase it suggested the absence of invasion during infection.  However, in a 
serendipitous experiment, we found F1 expression to be dramatically reduced under 
atmospheric levels of oxygen invasive ability concomitantly increased.  We speculated 
that reduced F1 under high oxygen conditions may be an adaptation to efficient 
transmission by droplet infection.   The results of preliminary infection experiments do 
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not provide support for this hypothesis.  In contrast, they suggest that F1 either promotes 
transit to the lungs or provides significant resistance to against pulmonary defenses. 
 
The role of F1 in vivo remains ambiguous.  While some studies support the idea that F1 
inhibits infection of rodents, other studies suggest that F1 plays no role.  Additional 
studies utilizing the F1 mutants created in fully virulent KIM1001 will help elucidate the 
role of F1 in colonization and transit to the lungs.  Additional work will also be neededto 
determine how F1 expression is regulated by oxygen, and if other virulence factors are 
also affected by oxygen concentration.  Analysis of mutants with altered patterns of F1 
expression and mutants defective in redox cycling will be important in revealing the 
mechanism of regulation.    
 
 
 
 
 
 
  
 
  
 
. 
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